|
OMIM |
Link |
Information gain |
01 |
|
MAFD6
|
[NCBI]
|
0.00504777
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00355492
|
|
|
APOE
|
[NCBI]
|
0.00324396
|
|
|
MAFD1
|
[NCBI]
|
0.00263895
|
|
|
IDDM
|
[NCBI]
|
0.00177127
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.00122862
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.00102345
|
|
|
PEE1
|
[NCBI]
|
0.00100846
|
|
|
HSCR9
|
[NCBI]
|
0.000977552
|
|
|
CHDS8
|
[NCBI]
|
0.000977552
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000977552
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000977552
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000977552
|
|
|
SCZD7
|
[NCBI]
|
0.000945864
|
|
|
GC
|
[NCBI]
|
0.00090239
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000893962
|
|
|
HPCX
|
[NCBI]
|
0.000879017
|
|
|
EGF
|
[NCBI]
|
0.000821841
|
|
|
IBD5
|
[NCBI]
|
0.000820431
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000818316
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.000818316
|
|
|
ESD
|
[NCBI]
|
0.000749416
|
|
|
torus palatinus and torus mandibularis
|
[NCBI]
|
0.000710846
|
|
|
ETM2
|
[NCBI]
|
0.000710846
|
|
|
wegener granulomatosis
|
[NCBI]
|
0.000668094
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000668094
|
|
|
AMCX5
|
[NCBI]
|
0.000668094
|
|
|
DFNA25
|
[NCBI]
|
0.000668094
|
|
|
hypertension, essential, susceptibility to, 3
|
[NCBI]
|
0.000668094
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000668094
|
|
|
OTSC2
|
[NCBI]
|
0.000668094
|
|
|
ATFB5
|
[NCBI]
|
0.000668094
|
|
|
STHAG5
|
[NCBI]
|
0.000668094
|
|
|
ATFB2
|
[NCBI]
|
0.000668094
|
|
|
HDLCQ1
|
[NCBI]
|
0.000668094
|
|
|
PSORS4
|
[NCBI]
|
0.000565184
|
|
|
HP
|
[NCBI]
|
0.000544958
|
|
|
AD
|
[NCBI]
|
0.000542038
|
|
|
COMT
|
[NCBI]
|
0.000532716
|
|
|
NGFB
|
[NCBI]
|
0.000518333
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000511604
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000511604
|
|
|
behcet syndrome
|
[NCBI]
|
0.000461527
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000426687
|
|
|
VEGF
|
[NCBI]
|
0.000417924
|
|
|
esophagitis, eosinophilic
|
[NCBI]
|
0.000408778
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.000408778
|
|
|
breast cancer, 11-22 translocation associated
|
[NCBI]
|
0.000408778
|
|
|
IBD4
|
[NCBI]
|
0.000408778
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.000408778
|
|
|
osteoarthropathy of fingers, familial
|
[NCBI]
|
0.000408778
|
|
|
FSHMD1B
|
[NCBI]
|
0.000408778
|
|
|
intelligence quantitative trait locus 1
|
[NCBI]
|
0.000408778
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.000408778
|
|
|
MAFD4
|
[NCBI]
|
0.000408778
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.000408778
|
|
|
TF
|
[NCBI]
|
0.000404536
|
|
|
OTSC1
|
[NCBI]
|
0.000392104
|
|
|
osteoarthritis
|
[NCBI]
|
0.00038672
|
|
|
EIG
|
[NCBI]
|
0.000381493
|
|
|
PRL
|
[NCBI]
|
0.000380512
|
|
|
HFE
|
[NCBI]
|
0.000368363
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000362577
|
|
|
PSORS2
|
[NCBI]
|
0.000361407
|
|
|
autism
|
[NCBI]
|
0.000355163
|
|
|
MTHFR
|
[NCBI]
|
0.000343096
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000329224
|
|
|
TSD
|
[NCBI]
|
0.000328675
|
|
|
AVP
|
[NCBI]
|
0.000326982
|
|
|
pelvic organ prolapse
|
[NCBI]
|
0.000314575
|
|
|
CFM1
|
[NCBI]
|
0.000314575
|
|
|
IDDM13
|
[NCBI]
|
0.000314575
|
|
|
STUT1
|
[NCBI]
|
0.000314575
|
|
|
IBD6
|
[NCBI]
|
0.000314575
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.000314575
|
|
|
SEMDIT
|
[NCBI]
|
0.000314575
|
|
|
IDDM11
|
[NCBI]
|
0.000314575
|
|
|
anodontia of permanent dentition
|
[NCBI]
|
0.000314575
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000314575
|
|
|
ORW3
|
[NCBI]
|
0.000314575
|
|
|
IDDM18
|
[NCBI]
|
0.000314575
|
|
|
preauricular fistulae, congenital
|
[NCBI]
|
0.000314575
|
|
|
musk, inability to smell
|
[NCBI]
|
0.000314575
|
|
|
CFH
|
[NCBI]
|
0.000311651
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000309105
|
|
|
CD
|
[NCBI]
|
0.000307166
|
|
|
IBD1
|
[NCBI]
|
0.000300644
|
|
|
KLK3
|
[NCBI]
|
0.00029511
|
|
|
MS
|
[NCBI]
|
0.000294948
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000286583
|
|
|
SCZD
|
[NCBI]
|
0.000284506
|
|
|
GFAP
|
[NCBI]
|
0.000275659
|
|
|
EGFR
|
[NCBI]
|
0.000275137
|
|
|
PWS
|
[NCBI]
|
0.000274665
|
|
|
IS1
|
[NCBI]
|
0.000274025
|
|
|
PTH
|
[NCBI]
|
0.000271724
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000271032
|
|
|
PGM1
|
[NCBI]
|
0.000265409
|
|
|
SCA6
|
[NCBI]
|
0.000262114
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000261629
|
|
|
TPMT
|
[NCBI]
|
0.000260246
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
0.00025547
|
|
|
CELIAC6
|
[NCBI]
|
0.00025547
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.00025547
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.00025547
|
|
|
PN
|
[NCBI]
|
0.00025547
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.00025547
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.00025547
|
|
|
CMT2B2
|
[NCBI]
|
0.00025547
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.00025547
|
|
|
OB10P
|
[NCBI]
|
0.00025547
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.00025547
|
|
|
DFNB15
|
[NCBI]
|
0.00025547
|
|
|
SCZD5
|
[NCBI]
|
0.00025547
|
|
|
BRCA3
|
[NCBI]
|
0.00025547
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.00025547
|
|
|
CHDM
|
[NCBI]
|
0.00025547
|
|
|
prostate cancer
|
[NCBI]
|
0.000251579
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000251544
|
|
|
OFC1
|
[NCBI]
|
0.000250555
|
|
|
ACHE
|
[NCBI]
|
0.000248371
|
|
|
CEACAM5
|
[NCBI]
|
0.000247132
|
|
|
VDR
|
[NCBI]
|
0.000242381
|
|
|
ACE
|
[NCBI]
|
0.000237073
|
|
|
EPO
|
[NCBI]
|
0.000233693
|
|
|
MBL2
|
[NCBI]
|
0.000233462
|
|
|
NPY
|
[NCBI]
|
0.000230256
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000229848
|
|
|
IGAN1
|
[NCBI]
|
0.000229848
|
|
|
FMF
|
[NCBI]
|
0.000226292
|
|
|
MAOA
|
[NCBI]
|
0.000223485
|
|
|
PON1
|
[NCBI]
|
0.000216551
|
|
|
CELIAC2
|
[NCBI]
|
0.000213034
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000213034
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000213034
|
|
|
SPG23
|
[NCBI]
|
0.000213034
|
|
|
AD14
|
[NCBI]
|
0.000213034
|
|
|
DYT7
|
[NCBI]
|
0.000213034
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.000213034
|
|
|
OFC3
|
[NCBI]
|
0.000213034
|
|
|
AD13
|
[NCBI]
|
0.000213034
|
|
|
HGF
|
[NCBI]
|
0.000211514
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000201739
|
|
|
DRD4
|
[NCBI]
|
0.000196892
|
|
|
AFP
|
[NCBI]
|
0.000186709
|
|
|
ear wax, wet/dry
|
[NCBI]
|
0.000181001
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
0.000181001
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000180416
|
|
|
PFHB1B
|
[NCBI]
|
0.000180416
|
|
|
SCZD10
|
[NCBI]
|
0.000180416
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.000180416
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.000180416
|
|
|
EOCA
|
[NCBI]
|
0.000180416
|
|
|
HPC10
|
[NCBI]
|
0.000180416
|
|
|
GBY
|
[NCBI]
|
0.000180416
|
|
|
GJB2
|
[NCBI]
|
0.000180144
|
|
|
LEPR
|
[NCBI]
|
0.000178636
|
|
|
G6PD
|
[NCBI]
|
0.000174594
|
|
|
FIDD
|
[NCBI]
|
0.000172903
|
|
|
CRH
|
[NCBI]
|
0.000168608
|
|
|
phenylketonuria
|
[NCBI]
|
0.000167161
|
|
|
CCR5
|
[NCBI]
|
0.000165842
|
|
|
lactase persistence
|
[NCBI]
|
0.000164223
|
|
|
LRRK2
|
[NCBI]
|
0.000160453
|
|
|
NPPA
|
[NCBI]
|
0.000155125
|
|
|
HMN1
|
[NCBI]
|
0.000154286
|
|
|
SPG5A
|
[NCBI]
|
0.000154286
|
|
|
cluster headache, familial
|
[NCBI]
|
0.000154286
|
|
|
BMND3
|
[NCBI]
|
0.000154286
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
0.000151095
|
|
|
graves disease
|
[NCBI]
|
0.000147235
|
|
|
NOD2
|
[NCBI]
|
0.00014573
|
|
|
APOH
|
[NCBI]
|
0.000145669
|
|
|
SAL-I
|
[NCBI]
|
0.000144939
|
|
|
xh antigen
|
[NCBI]
|
0.000144939
|
|
|
SHEP4
|
[NCBI]
|
0.000144939
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000143474
|
|
|
sarcoidosis
|
[NCBI]
|
0.000141247
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000139027
|
|
|
F3
|
[NCBI]
|
0.000137379
|
|
|
TH
|
[NCBI]
|
0.000136683
|
|
|
CHAT
|
[NCBI]
|
0.00013547
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
0.000135446
|
|
|
A2M
|
[NCBI]
|
0.000135422
|
|
|
alzheimer disease 2
|
[NCBI]
|
0.000134059
|
|
|
SHEP1
|
[NCBI]
|
0.000134059
|
|
|
HSCR1
|
[NCBI]
|
0.000133915
|
|
|
gastroesophageal reflux
|
[NCBI]
|
0.000132767
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.000132767
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.000132767
|
|
|
achoo syndrome
|
[NCBI]
|
0.000132767
|
|
|
MJD
|
[NCBI]
|
0.000130847
|
|
|
obesity
|
[NCBI]
|
0.000127697
|
|
|
ARMD4
|
[NCBI]
|
0.000127559
|
|
|
GPI
|
[NCBI]
|
0.000127201
|
|
|
CCK
|
[NCBI]
|
0.000125293
|
|
|
CAPN10
|
[NCBI]
|
0.00012472
|
|
|
LDLR
|
[NCBI]
|
0.000124371
|
|
|
PI
|
[NCBI]
|
0.000124043
|
|
|
SHEP3
|
[NCBI]
|
0.00012383
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
0.00012383
|
|
|
thiourea tasting
|
[NCBI]
|
0.000122676
|
|
|
PLG
|
[NCBI]
|
0.000119982
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000119161
|
|
|
IL6R
|
[NCBI]
|
0.000117645
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000116524
|
|
|
FRDA
|
[NCBI]
|
0.000115133
|
|
|
CDB2
|
[NCBI]
|
0.000114697
|
|
|
IGES
|
[NCBI]
|
0.000114697
|
|
|
SCZD6
|
[NCBI]
|
0.000114697
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
0.000114114
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
0.000114114
|
|
|
kuru, susceptibility to
|
[NCBI]
|
0.000114114
|
|
|
MC1R
|
[NCBI]
|
0.000112666
|
|
|
CAT
|
[NCBI]
|
0.00011208
|
|
|
neural tube defects
|
[NCBI]
|
0.000111725
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
0.000111175
|
|
|
MICA
|
[NCBI]
|
0.000111092
|
|
|
CFB
|
[NCBI]
|
0.000108042
|
|
|
PPROM
|
[NCBI]
|
0.000107227
|
|
|
CELIAC3
|
[NCBI]
|
0.000107227
|
|
|
SHEP5
|
[NCBI]
|
0.000107227
|
|
|
RA
|
[NCBI]
|
0.000106644
|
|
|
NIDDM1
|
[NCBI]
|
0.000105922
|
|
|
PSORS1
|
[NCBI]
|
0.000104613
|
|
|
ELAC2
|
[NCBI]
|
0.000101772
|
|
|
APOB
|
[NCBI]
|
0.000100126
|
|
|
gaucher disease, type i
|
[NCBI]
|
9.94711e-05
|
|
|
centralopathic epilepsy
|
[NCBI]
|
9.9303e-05
|
|
|
PARK3
|
[NCBI]
|
9.9303e-05
|
|
|
dermatitis, atopic
|
[NCBI]
|
9.9303e-05
|
|
|
CTLN2
|
[NCBI]
|
9.8853e-05
|
|
|
ARSA
|
[NCBI]
|
9.86672e-05
|
|
|
TCF7L2
|
[NCBI]
|
9.8328e-05
|
|
|
LPL
|
[NCBI]
|
9.63905e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
9.26496e-05
|
|
|
PPARG
|
[NCBI]
|
9.23175e-05
|
|
|
OCA2
|
[NCBI]
|
9.1177e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
9.1177e-05
|
|
|
pars planitis
|
[NCBI]
|
9.04812e-05
|
|
|
hypertension, essential
|
[NCBI]
|
8.90285e-05
|
|
|
ORM1
|
[NCBI]
|
8.894e-05
|
|
|
MBP
|
[NCBI]
|
8.82754e-05
|
|
|
TS
|
[NCBI]
|
8.80054e-05
|
|
|
LPA
|
[NCBI]
|
8.7374e-05
|
|
|
MEFV
|
[NCBI]
|
8.72848e-05
|
|
|
acheiropody
|
[NCBI]
|
8.71332e-05
|
|
|
DRD2
|
[NCBI]
|
8.71299e-05
|
|
|
NAT1
|
[NCBI]
|
8.71299e-05
|
|
|
WAS
|
[NCBI]
|
8.68342e-05
|
|
|
pygmy
|
[NCBI]
|
8.60477e-05
|
|
|
AUTS6
|
[NCBI]
|
8.60477e-05
|
|
|
NOS3
|
[NCBI]
|
8.32788e-05
|
|
|
SCA2
|
[NCBI]
|
8.27595e-05
|
|
|
ALD
|
[NCBI]
|
7.92021e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
7.91565e-05
|
|
|
LTA
|
[NCBI]
|
7.89045e-05
|
|
|
lung cancer
|
[NCBI]
|
7.82662e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
7.7683e-05
|
|
|
IGER
|
[NCBI]
|
7.74448e-05
|
|
|
GDNF
|
[NCBI]
|
7.71503e-05
|
|
|
HNMT
|
[NCBI]
|
7.64546e-05
|
|
|
AS
|
[NCBI]
|
7.62328e-05
|
|
|
DFNB1
|
[NCBI]
|
7.55323e-05
|
|
|
FABP2
|
[NCBI]
|
7.4668e-05
|
|
|
anencephaly
|
[NCBI]
|
7.45404e-05
|
|
|
DYT2
|
[NCBI]
|
7.45404e-05
|
|
|
PTPN22
|
[NCBI]
|
7.38356e-05
|
|
|
HEXA
|
[NCBI]
|
7.33413e-05
|
|
|
ORM2
|
[NCBI]
|
7.31274e-05
|
|
|
MCM6
|
[NCBI]
|
7.31274e-05
|
|
|
NFLD
|
[NCBI]
|
7.24643e-05
|
|
|
coronary heart disease, susceptibility to, 7
|
[NCBI]
|
7.24643e-05
|
|
|
leukocyte nuclear appendages, hereditary prevalence of
|
[NCBI]
|
7.24643e-05
|
|
|
tinea imbricata, susceptibility to
|
[NCBI]
|
7.24643e-05
|
|
|
blood group--public systems
|
[NCBI]
|
7.24643e-05
|
|
|
pa polymorphism of alpha-2-globulin
|
[NCBI]
|
7.24643e-05
|
|
|
blood group--private systems
|
[NCBI]
|
7.24643e-05
|
|
|
phenformin 4-hydroxylation
|
[NCBI]
|
7.24643e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
7.15523e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
7.06054e-05
|
|
|
IL1A
|
[NCBI]
|
7.0487e-05
|
|
|
wilson disease
|
[NCBI]
|
7.03328e-05
|
|
|
APC
|
[NCBI]
|
6.99674e-05
|
|
|
BRCA1
|
[NCBI]
|
6.98895e-05
|
|
|
PARK6
|
[NCBI]
|
6.9815e-05
|
|
|
DYT1
|
[NCBI]
|
6.9709e-05
|
|
|
ESR1
|
[NCBI]
|
6.87123e-05
|
|
|
IDUA
|
[NCBI]
|
6.83441e-05
|
|
|
IL1RN
|
[NCBI]
|
6.8291e-05
|
|
|
MTR
|
[NCBI]
|
6.76783e-05
|
|
|
CYP3A5
|
[NCBI]
|
6.75371e-05
|
|
|
UGT1A1
|
[NCBI]
|
6.71057e-05
|
|
|
HPC1
|
[NCBI]
|
6.63381e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
6.61581e-05
|
|
|
TNFSF6
|
[NCBI]
|
6.58326e-05
|
|
|
MFS
|
[NCBI]
|
6.54219e-05
|
|
|
GNRH1
|
[NCBI]
|
6.51317e-05
|
|
|
PRH1
|
[NCBI]
|
6.51229e-05
|
|
|
CBBM
|
[NCBI]
|
6.44888e-05
|
|
|
IDDM4
|
[NCBI]
|
6.44888e-05
|
|
|
body mass index
|
[NCBI]
|
6.37618e-05
|
|
|
CO
|
[NCBI]
|
6.37618e-05
|
|
|
LSFC
|
[NCBI]
|
6.37618e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
6.3578e-05
|
|
|
CYP2D6
|
[NCBI]
|
6.34198e-05
|
|
|
SHEP2
|
[NCBI]
|
6.31143e-05
|
|
|
DMD
|
[NCBI]
|
6.29336e-05
|
|
|
DTNBP1
|
[NCBI]
|
6.29076e-05
|
|
|
SGSH
|
[NCBI]
|
6.29076e-05
|
|
|
SHH
|
[NCBI]
|
6.27021e-05
|
|
|
AGT
|
[NCBI]
|
6.25783e-05
|
|
|
LEP
|
[NCBI]
|
6.0865e-05
|
|
|
AHSG
|
[NCBI]
|
6.07919e-05
|
|
|
ATXN8OS
|
[NCBI]
|
6.07919e-05
|
|
|
ADH2
|
[NCBI]
|
6.07919e-05
|
|
|
ATP7B
|
[NCBI]
|
6.02844e-05
|
|
|
FY
|
[NCBI]
|
6.02844e-05
|
|
|
MPO
|
[NCBI]
|
5.91783e-05
|
|
|
CMPK1
|
[NCBI]
|
5.89623e-05
|
|
|
CTLA4
|
[NCBI]
|
5.83757e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
5.82384e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
5.80803e-05
|
|
|
PARK7
|
[NCBI]
|
5.80803e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
5.80803e-05
|
|
|
JBTS3
|
[NCBI]
|
5.80803e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
5.73108e-05
|
|
|
PARK8
|
[NCBI]
|
5.73108e-05
|
|
|
SLC11A1
|
[NCBI]
|
5.71664e-05
|
|
|
temporal arteritis
|
[NCBI]
|
5.63126e-05
|
|
|
ADRB3
|
[NCBI]
|
5.553e-05
|
|
|
BL
|
[NCBI]
|
5.50255e-05
|
|
|
SCA1
|
[NCBI]
|
5.4652e-05
|
|
|
INSIG2
|
[NCBI]
|
5.45382e-05
|
|
|
PRB1
|
[NCBI]
|
5.45382e-05
|
|
|
ABCB1
|
[NCBI]
|
5.44658e-05
|
|
|
GALK1
|
[NCBI]
|
5.39692e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
5.32427e-05
|
|
|
iron overload in africa
|
[NCBI]
|
5.32427e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
5.32427e-05
|
|
|
GIST
|
[NCBI]
|
5.27992e-05
|
|
|
A1BG
|
[NCBI]
|
5.27193e-05
|
|
|
g30 gene
|
[NCBI]
|
5.27193e-05
|
|
|
ADAM33
|
[NCBI]
|
5.27193e-05
|
|
|
DRD3
|
[NCBI]
|
5.24971e-05
|
|
|
ADH3
|
[NCBI]
|
5.20957e-05
|
|
|
NRG1
|
[NCBI]
|
5.18372e-05
|
|
|
BRCA2
|
[NCBI]
|
5.11862e-05
|
|
|
DBH
|
[NCBI]
|
5.11047e-05
|
|
|
GBA
|
[NCBI]
|
5.08784e-05
|
|
|
MTCO2
|
[NCBI]
|
5.07033e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
4.90464e-05
|
|
|
PRB3
|
[NCBI]
|
4.80996e-05
|
|
|
g72 gene
|
[NCBI]
|
4.80996e-05
|
|
|
CHEK2
|
[NCBI]
|
4.79867e-05
|
|
|
TPH2
|
[NCBI]
|
4.79135e-05
|
|
|
twinning, dizygotic
|
[NCBI]
|
4.79027e-05
|
|
|
PAND1
|
[NCBI]
|
4.79027e-05
|
|
|
osteoporosis
|
[NCBI]
|
4.77045e-05
|
|
|
APOA1
|
[NCBI]
|
4.66677e-05
|
|
|
NIDDM
|
[NCBI]
|
4.63892e-05
|
|
|
GLO1
|
[NCBI]
|
4.61922e-05
|
|
|
PGP
|
[NCBI]
|
4.61922e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
4.53541e-05
|
|
|
GVM
|
[NCBI]
|
4.53541e-05
|
|
|
DFNA12
|
[NCBI]
|
4.53541e-05
|
|
|
OCD1
|
[NCBI]
|
4.53541e-05
|
|
|
immune deficiency, familial variable
|
[NCBI]
|
4.52358e-05
|
|
|
SHEP9
|
[NCBI]
|
4.52358e-05
|
|
|
buerger disease
|
[NCBI]
|
4.52358e-05
|
|
|
pilomatrixoma
|
[NCBI]
|
4.52358e-05
|
|
|
hypophosphatasia, childhood
|
[NCBI]
|
4.52358e-05
|
|
|
favism, susceptibility to
|
[NCBI]
|
4.52358e-05
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
4.52358e-05
|
|
|
sjogren-larsson-like ichthyosis without cns or eye involvement
|
[NCBI]
|
4.52358e-05
|
|
|
DFNB28
|
[NCBI]
|
4.52358e-05
|
|
|
blepharospasm, benign essential
|
[NCBI]
|
4.52358e-05
|
|
|
PDCD1
|
[NCBI]
|
4.44215e-05
|
|
|
RNASE3
|
[NCBI]
|
4.39745e-05
|
|
|
GTS
|
[NCBI]
|
4.39622e-05
|
|
|
ADA
|
[NCBI]
|
4.38551e-05
|
|
|
PRNP
|
[NCBI]
|
4.32285e-05
|
|
|
CRC
|
[NCBI]
|
4.29815e-05
|
|
|
CYP1A2
|
[NCBI]
|
4.28721e-05
|
|
|
C4A
|
[NCBI]
|
4.25112e-05
|
|
|
DHFR
|
[NCBI]
|
4.23059e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
4.20687e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
4.20687e-05
|
|
|
SLC25A13
|
[NCBI]
|
4.15614e-05
|
|
|
SLC45A2
|
[NCBI]
|
4.14307e-05
|
|
|
USH2A
|
[NCBI]
|
4.14307e-05
|
|
|
C7
|
[NCBI]
|
4.14307e-05
|
|
|
CFTR
|
[NCBI]
|
4.1169e-05
|
|
|
IL1B
|
[NCBI]
|
4.11667e-05
|
|
|
ACADM
|
[NCBI]
|
4.11231e-05
|
|
|
MRX1
|
[NCBI]
|
4.1051e-05
|
|
|
TG
|
[NCBI]
|
4.08825e-05
|
|
|
ALAD
|
[NCBI]
|
4.04623e-05
|
|
|
HLA-A
|
[NCBI]
|
4.03923e-05
|
|
|
SPDA1
|
[NCBI]
|
4.00375e-05
|
|
|
HLA-B
|
[NCBI]
|
3.94171e-05
|
|
|
MAOB
|
[NCBI]
|
3.94171e-05
|
|
|
MUC1
|
[NCBI]
|
3.9226e-05
|
|
|
CMT2A1
|
[NCBI]
|
3.91186e-05
|
|
|
BMND1
|
[NCBI]
|
3.91186e-05
|
|
|
ACTN3
|
[NCBI]
|
3.90698e-05
|
|
|
PRH2
|
[NCBI]
|
3.90698e-05
|
|
|
IL10
|
[NCBI]
|
3.88385e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
3.87436e-05
|
|
|
H6PD
|
[NCBI]
|
3.83461e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
3.81455e-05
|
|
|
galactosemia
|
[NCBI]
|
3.80484e-05
|
|
|
FMO3
|
[NCBI]
|
3.77884e-05
|
|
|
NCSTN
|
[NCBI]
|
3.76321e-05
|
|
|
IL2
|
[NCBI]
|
3.73715e-05
|
|
|
SLC24A5
|
[NCBI]
|
3.70966e-05
|
|
|
SACP
|
[NCBI]
|
3.70966e-05
|
|
|
SPP1
|
[NCBI]
|
3.70459e-05
|
|
|
NRCLP1
|
[NCBI]
|
3.67502e-05
|
|
|
protocadherin-alpha gene cluster
|
[NCBI]
|
3.64497e-05
|
|
|
BHD
|
[NCBI]
|
3.64497e-05
|
|
|
SCZD9
|
[NCBI]
|
3.64497e-05
|
|
|
ACHM2
|
[NCBI]
|
3.64497e-05
|
|
|
CF
|
[NCBI]
|
3.63266e-05
|
|
|
ADCYAP1
|
[NCBI]
|
3.60009e-05
|
|
|
C3
|
[NCBI]
|
3.5669e-05
|
|
|
ALDH2
|
[NCBI]
|
3.55418e-05
|
|
|
abdominal body fat distribution
|
[NCBI]
|
3.52982e-05
|
|
|
isovaleric acid, inability to smell
|
[NCBI]
|
3.52982e-05
|
|
|
PLT1
|
[NCBI]
|
3.52982e-05
|
|
|
tracheoesophageal fistula with or without esophageal atresia
|
[NCBI]
|
3.52982e-05
|
|
|
CVT
|
[NCBI]
|
3.52982e-05
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
3.52982e-05
|
|
|
dystonia, familial, with visual failure and striatal lucencies
|
[NCBI]
|
3.52982e-05
|
|
|
earlobe attachment: attached vs unattached
|
[NCBI]
|
3.52982e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
3.52982e-05
|
|
|
SLEB2
|
[NCBI]
|
3.52982e-05
|
|
|
F2
|
[NCBI]
|
3.51282e-05
|
|
|
TPI1
|
[NCBI]
|
3.48396e-05
|
|
|
OPTN
|
[NCBI]
|
3.48396e-05
|
|
|
AACT
|
[NCBI]
|
3.44412e-05
|
|
|
CA1
|
[NCBI]
|
3.44412e-05
|
|
|
breast cancer
|
[NCBI]
|
3.42265e-05
|
|
|
C4B
|
[NCBI]
|
3.41586e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
3.40201e-05
|
|
|
PALS
|
[NCBI]
|
3.40201e-05
|
|
|
RET
|
[NCBI]
|
3.38895e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
3.37605e-05
|
|
|
LHB
|
[NCBI]
|
3.34836e-05
|
|
|
MYOC
|
[NCBI]
|
3.33835e-05
|
|
|
loc387715 gene
|
[NCBI]
|
3.33142e-05
|
|
|
ASPM
|
[NCBI]
|
3.33142e-05
|
|
|
CJD
|
[NCBI]
|
3.30982e-05
|
|
|
ITGB3
|
[NCBI]
|
3.25878e-05
|
|
|
SMA1
|
[NCBI]
|
3.25128e-05
|
|
|
LRP1
|
[NCBI]
|
3.23345e-05
|
|
|
TLR4
|
[NCBI]
|
3.22473e-05
|
|
|
DRPLA
|
[NCBI]
|
3.20794e-05
|
|
|
PIK3CB
|
[NCBI]
|
3.2065e-05
|
|
|
PLEKHA1
|
[NCBI]
|
3.2065e-05
|
|
|
PRB4
|
[NCBI]
|
3.2065e-05
|
|
|
MUC7
|
[NCBI]
|
3.2065e-05
|
|
|
PFIC1
|
[NCBI]
|
3.17964e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
3.17964e-05
|
|
|
GCE
|
[NCBI]
|
3.17964e-05
|
|
|
DLB
|
[NCBI]
|
3.17964e-05
|
|
|
NPC2
|
[NCBI]
|
3.17834e-05
|
|
|
HTR2A
|
[NCBI]
|
3.17008e-05
|
|
|
hurler syndrome
|
[NCBI]
|
3.14875e-05
|
|
|
FGF7
|
[NCBI]
|
3.1312e-05
|
|
|
GAPDH
|
[NCBI]
|
3.10519e-05
|
|
|
IL4R
|
[NCBI]
|
3.08686e-05
|
|
|
HD
|
[NCBI]
|
3.04405e-05
|
|
|
MCOLN1
|
[NCBI]
|
3.03904e-05
|
|
|
SFTPA1
|
[NCBI]
|
3.03904e-05
|
|
|
MSR1
|
[NCBI]
|
3.03904e-05
|
|
|
IKBKAP
|
[NCBI]
|
3.03904e-05
|
|
|
ADH1
|
[NCBI]
|
3.03904e-05
|
|
|
GPX1
|
[NCBI]
|
3.00718e-05
|
|
|
PF4
|
[NCBI]
|
3.00402e-05
|
|
|
sandhoff disease
|
[NCBI]
|
2.97528e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
2.97521e-05
|
|
|
longevity
|
[NCBI]
|
2.97521e-05
|
|
|
alkaptonuria
|
[NCBI]
|
2.97521e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
2.97521e-05
|
|
|
proteus syndrome
|
[NCBI]
|
2.96524e-05
|
|
|
PCSK9
|
[NCBI]
|
2.91137e-05
|
|
|
carboxypeptidase n deficiency
|
[NCBI]
|
2.90359e-05
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
2.90359e-05
|
|
|
raph blood group system
|
[NCBI]
|
2.90359e-05
|
|
|
CMM3
|
[NCBI]
|
2.90359e-05
|
|
|
clubfoot
|
[NCBI]
|
2.90359e-05
|
|
|
varicose veins
|
[NCBI]
|
2.90359e-05
|
|
|
cyanide, inability to smell
|
[NCBI]
|
2.90359e-05
|
|
|
AIS1
|
[NCBI]
|
2.90359e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
2.90359e-05
|
|
|
DI
|
[NCBI]
|
2.90359e-05
|
|
|
EEG
|
[NCBI]
|
2.90359e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
2.90359e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
2.90359e-05
|
|
|
SMAX1
|
[NCBI]
|
2.89859e-05
|
|
|
GABRA5
|
[NCBI]
|
2.86433e-05
|
|
|
CDKAL1
|
[NCBI]
|
2.86433e-05
|
|
|
ABAT
|
[NCBI]
|
2.86433e-05
|
|
|
MX1
|
[NCBI]
|
2.86433e-05
|
|
|
LQT1
|
[NCBI]
|
2.86255e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
2.86113e-05
|
|
|
NOS2A
|
[NCBI]
|
2.85745e-05
|
|
|
ME2
|
[NCBI]
|
2.79365e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.78695e-05
|
|
|
NPC1
|
[NCBI]
|
2.78695e-05
|
|
|
DPYD
|
[NCBI]
|
2.78695e-05
|
|
|
isoniazid inactivation
|
[NCBI]
|
2.73156e-05
|
|
|
CAPN3
|
[NCBI]
|
2.71911e-05
|
|
|
ALPL
|
[NCBI]
|
2.71911e-05
|
|
|
PYY
|
[NCBI]
|
2.68612e-05
|
|
|
MC3R
|
[NCBI]
|
2.68452e-05
|
|
|
FLG
|
[NCBI]
|
2.68452e-05
|
|
|
ADIPOR1
|
[NCBI]
|
2.68452e-05
|
|
|
FCGR3A
|
[NCBI]
|
2.68452e-05
|
|
|
POMC
|
[NCBI]
|
2.67177e-05
|
|
|
ENPP1
|
[NCBI]
|
2.65376e-05
|
|
|
oca2 gene
|
[NCBI]
|
2.65376e-05
|
|
|
GALT
|
[NCBI]
|
2.63654e-05
|
|
|
aHUS
|
[NCBI]
|
2.62302e-05
|
|
|
CASQ1
|
[NCBI]
|
2.60452e-05
|
|
|
ALG6
|
[NCBI]
|
2.60452e-05
|
|
|
SAA1
|
[NCBI]
|
2.59075e-05
|
|
|
PROCR
|
[NCBI]
|
2.59067e-05
|
|
|
RNASEL
|
[NCBI]
|
2.58291e-05
|
|
|
SCZD3
|
[NCBI]
|
2.49329e-05
|
|
|
CBP
|
[NCBI]
|
2.48793e-05
|
|
|
GLDC
|
[NCBI]
|
2.48793e-05
|
|
|
PSEN1
|
[NCBI]
|
2.4768e-05
|
|
|
ICAM1
|
[NCBI]
|
2.47117e-05
|
|
|
PSEN2
|
[NCBI]
|
2.45918e-05
|
|
|
ODG1
|
[NCBI]
|
2.45192e-05
|
|
|
insulin-like growth factor i deficiency
|
[NCBI]
|
2.45192e-05
|
|
|
fragile site 10q25
|
[NCBI]
|
2.45192e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
2.45192e-05
|
|
|
IDDM10
|
[NCBI]
|
2.45192e-05
|
|
|
DFNB12
|
[NCBI]
|
2.45192e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
2.45192e-05
|
|
|
KRS
|
[NCBI]
|
2.45192e-05
|
|
|
TINU
|
[NCBI]
|
2.45192e-05
|
|
|
novelty seeking personality trait
|
[NCBI]
|
2.45192e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
2.45192e-05
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
2.45192e-05
|
|
|
IN
|
[NCBI]
|
2.45192e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
2.45192e-05
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
2.45192e-05
|
|
|
SCA10
|
[NCBI]
|
2.44944e-05
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
2.44944e-05
|
|
|
RTT
|
[NCBI]
|
2.4265e-05
|
|
|
RNPEPL1
|
[NCBI]
|
2.41764e-05
|
|
|
MCCD1
|
[NCBI]
|
2.41764e-05
|
|
|
neutrophil-specific antigen: ne1
|
[NCBI]
|
2.41764e-05
|
|
|
twirler mutation, murine, human homolog of
|
[NCBI]
|
2.41764e-05
|
|
|
lymphocyte cytosol polypeptide, 100-kd
|
[NCBI]
|
2.41764e-05
|
|
|
ESB3
|
[NCBI]
|
2.41764e-05
|
|
|
TCTE1
|
[NCBI]
|
2.41764e-05
|
|
|
ACP1
|
[NCBI]
|
2.41437e-05
|
|
|
PGM3
|
[NCBI]
|
2.39882e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
2.39882e-05
|
|
|
MMP8
|
[NCBI]
|
2.39542e-05
|
|
|
PPP1R3A
|
[NCBI]
|
2.39542e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
2.39542e-05
|
|
|
RENBP
|
[NCBI]
|
2.39542e-05
|
|
|
IL23R
|
[NCBI]
|
2.39542e-05
|
|
|
AMY1A
|
[NCBI]
|
2.31498e-05
|
|
|
PGD
|
[NCBI]
|
2.31498e-05
|
|
|
CTGF
|
[NCBI]
|
2.29737e-05
|
|
|
PKLR
|
[NCBI]
|
2.25462e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
2.25462e-05
|
|
|
MAG
|
[NCBI]
|
2.24474e-05
|
|
|
CTSD
|
[NCBI]
|
2.23586e-05
|
|
|
CR1
|
[NCBI]
|
2.23586e-05
|
|
|
TMC1
|
[NCBI]
|
2.22082e-05
|
|
|
VKORC1
|
[NCBI]
|
2.22082e-05
|
|
|
CYP4A11
|
[NCBI]
|
2.22082e-05
|
|
|
SLC22A4
|
[NCBI]
|
2.22082e-05
|
|
|
HSAN3
|
[NCBI]
|
2.21575e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
2.21575e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
2.20463e-05
|
|
|
SLC6A3
|
[NCBI]
|
2.1913e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
2.16101e-05
|
|
|
FOXC2
|
[NCBI]
|
2.16101e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
2.16101e-05
|
|
|
LRE1
|
[NCBI]
|
2.16101e-05
|
|
|
ELN
|
[NCBI]
|
2.14747e-05
|
|
|
GIP
|
[NCBI]
|
2.13966e-05
|
|
|
CMT1A
|
[NCBI]
|
2.13813e-05
|
|
|
CD36
|
[NCBI]
|
2.11199e-05
|
|
|
HLA-DRA
|
[NCBI]
|
2.10904e-05
|
|
|
protocadherin-beta gene cluster
|
[NCBI]
|
2.10306e-05
|
|
|
DFNB7
|
[NCBI]
|
2.10306e-05
|
|
|
tibial hemimelia
|
[NCBI]
|
2.10306e-05
|
|
|
CRS2
|
[NCBI]
|
2.10306e-05
|
|
|
thrombophilia
|
[NCBI]
|
2.10306e-05
|
|
|
HOA
|
[NCBI]
|
2.10306e-05
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
2.10306e-05
|
|
|
PLAT
|
[NCBI]
|
2.09005e-05
|
|
|
CTSB
|
[NCBI]
|
2.09005e-05
|
|
|
WFS1
|
[NCBI]
|
2.09005e-05
|
|
|
STAT3
|
[NCBI]
|
2.07865e-05
|
|
|
VUR1
|
[NCBI]
|
2.07744e-05
|
|
|
CYSLTR1
|
[NCBI]
|
2.07129e-05
|
|
|
HTR2C
|
[NCBI]
|
2.07129e-05
|
|
|
MTRR
|
[NCBI]
|
2.07129e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
2.07129e-05
|
|
|
BRAF
|
[NCBI]
|
2.06331e-05
|
|
|
TPO
|
[NCBI]
|
2.04388e-05
|
|
|
BBS
|
[NCBI]
|
2.04302e-05
|
|
|
KSS
|
[NCBI]
|
2.04302e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
2.02514e-05
|
|
|
PSNP1
|
[NCBI]
|
2.02514e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
2.02514e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
2.02514e-05
|
|
|
USH2A
|
[NCBI]
|
2.02514e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
2.02514e-05
|
|
|
HSR
|
[NCBI]
|
2.02264e-05
|
|
|
CDSN
|
[NCBI]
|
2.02264e-05
|
|
|
IRF1
|
[NCBI]
|
2.02264e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.00989e-05
|
|
|
CDKN2A
|
[NCBI]
|
1.97558e-05
|
|
|
LRP5
|
[NCBI]
|
1.95847e-05
|
|
|
SLC3A1
|
[NCBI]
|
1.95847e-05
|
|
|
ELOVL4
|
[NCBI]
|
1.94079e-05
|
|
|
APOA5
|
[NCBI]
|
1.94079e-05
|
|
|
EPHX2
|
[NCBI]
|
1.94079e-05
|
|
|
CD151
|
[NCBI]
|
1.94079e-05
|
|
|
ASPN
|
[NCBI]
|
1.94079e-05
|
|
|
IMPDH1
|
[NCBI]
|
1.94079e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.93363e-05
|
|
|
SHBG
|
[NCBI]
|
1.9212e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
1.90144e-05
|
|
|
alcohol dependence
|
[NCBI]
|
1.90144e-05
|
|
|
BMP15
|
[NCBI]
|
1.89729e-05
|
|
|
CDKN1C
|
[NCBI]
|
1.89729e-05
|
|
|
BWS
|
[NCBI]
|
1.8959e-05
|
|
|
GH1
|
[NCBI]
|
1.89524e-05
|
|
|
ERBB2
|
[NCBI]
|
1.89272e-05
|
|
|
IFNG
|
[NCBI]
|
1.89272e-05
|
|
|
FSHR
|
[NCBI]
|
1.88195e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.8737e-05
|
|
|
AR
|
[NCBI]
|
1.85396e-05
|
|
|
PMCH
|
[NCBI]
|
1.84547e-05
|
|
|
TYR
|
[NCBI]
|
1.84514e-05
|
|
|
SLC22A5
|
[NCBI]
|
1.83887e-05
|
|
|
PTPN1
|
[NCBI]
|
1.83887e-05
|
|
|
BDNF
|
[NCBI]
|
1.83564e-05
|
|
|
PEPC
|
[NCBI]
|
1.82527e-05
|
|
|
PRND
|
[NCBI]
|
1.82527e-05
|
|
|
T
|
[NCBI]
|
1.82527e-05
|
|
|
NPPB
|
[NCBI]
|
1.82527e-05
|
|
|
SGCG
|
[NCBI]
|
1.82527e-05
|
|
|
MTNR1A
|
[NCBI]
|
1.82527e-05
|
|
|
PEX1
|
[NCBI]
|
1.82527e-05
|
|
|
AHR
|
[NCBI]
|
1.82285e-05
|
|
|
AN1
|
[NCBI]
|
1.82214e-05
|
|
|
CLN6
|
[NCBI]
|
1.82214e-05
|
|
|
LGMD1C
|
[NCBI]
|
1.82214e-05
|
|
|
HMS
|
[NCBI]
|
1.82214e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate b
|
[NCBI]
|
1.82214e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
1.82214e-05
|
|
|
SQT1
|
[NCBI]
|
1.82214e-05
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
1.82214e-05
|
|
|
GBS
|
[NCBI]
|
1.82214e-05
|
|
|
ALS4
|
[NCBI]
|
1.82214e-05
|
|
|
CDG1C
|
[NCBI]
|
1.82214e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
1.82214e-05
|
|
|
EV
|
[NCBI]
|
1.82117e-05
|
|
|
PBD
|
[NCBI]
|
1.78534e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
1.78534e-05
|
|
|
AICDA
|
[NCBI]
|
1.78299e-05
|
|
|
DYT1
|
[NCBI]
|
1.78299e-05
|
|
|
apc gene
|
[NCBI]
|
1.73109e-05
|
|
|
MCPH1
|
[NCBI]
|
1.72183e-05
|
|
|
tritanopia
|
[NCBI]
|
1.72183e-05
|
|
|
FUT3
|
[NCBI]
|
1.72183e-05
|
|
|
AMBP
|
[NCBI]
|
1.72183e-05
|
|
|
SOAT1
|
[NCBI]
|
1.72183e-05
|
|
|
IRF5
|
[NCBI]
|
1.72183e-05
|
|
|
PON2
|
[NCBI]
|
1.72183e-05
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
1.71207e-05
|
|
|
TSHR
|
[NCBI]
|
1.70717e-05
|
|
|
DISC1
|
[NCBI]
|
1.67819e-05
|
|
|
WBS
|
[NCBI]
|
1.66584e-05
|
|
|
CYP11B2
|
[NCBI]
|
1.62895e-05
|
|
|
CST3
|
[NCBI]
|
1.62895e-05
|
|
|
F13B
|
[NCBI]
|
1.62834e-05
|
|
|
KIR3DL1
|
[NCBI]
|
1.62834e-05
|
|
|
KLK1
|
[NCBI]
|
1.62834e-05
|
|
|
UCP1
|
[NCBI]
|
1.62549e-05
|
|
|
CBR3
|
[NCBI]
|
1.60318e-05
|
|
|
CCDC28B
|
[NCBI]
|
1.60318e-05
|
|
|
HYLS1
|
[NCBI]
|
1.60318e-05
|
|
|
mei1, mouse, homolog of
|
[NCBI]
|
1.60318e-05
|
|
|
LRCH1
|
[NCBI]
|
1.60318e-05
|
|
|
PGLYRP3
|
[NCBI]
|
1.60318e-05
|
|
|
DIA2
|
[NCBI]
|
1.60318e-05
|
|
|
TBCD
|
[NCBI]
|
1.60318e-05
|
|
|
CHRM4
|
[NCBI]
|
1.60318e-05
|
|
|
brain-specific protein pc-1
|
[NCBI]
|
1.60318e-05
|
|
|
CTTNBP2
|
[NCBI]
|
1.60318e-05
|
|
|
PGLYRP4
|
[NCBI]
|
1.60318e-05
|
|
|
CHI3L2
|
[NCBI]
|
1.60318e-05
|
|
|
HLA8
|
[NCBI]
|
1.60318e-05
|
|
|
yeast factor
|
[NCBI]
|
1.60318e-05
|
|
|
FABP6
|
[NCBI]
|
1.60318e-05
|
|
|
COX7B2
|
[NCBI]
|
1.60318e-05
|
|
|
MTNR1B
|
[NCBI]
|
1.60318e-05
|
|
|
GMIP
|
[NCBI]
|
1.60318e-05
|
|
|
XYLT2
|
[NCBI]
|
1.60318e-05
|
|
|
GPR35
|
[NCBI]
|
1.60318e-05
|
|
|
GFPT2
|
[NCBI]
|
1.60318e-05
|
|
|
STAT6
|
[NCBI]
|
1.60051e-05
|
|
|
AITD3
|
[NCBI]
|
1.58949e-05
|
|
|
VMCM
|
[NCBI]
|
1.58949e-05
|
|
|
SC
|
[NCBI]
|
1.58949e-05
|
|
|
RP10
|
[NCBI]
|
1.58949e-05
|
|
|
IDD
|
[NCBI]
|
1.58949e-05
|
|
|
MCOPS2
|
[NCBI]
|
1.58949e-05
|
|
|
ACHM3
|
[NCBI]
|
1.58949e-05
|
|
|
vitiligo
|
[NCBI]
|
1.58949e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
1.58949e-05
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
1.58949e-05
|
|
|
SLEB1
|
[NCBI]
|
1.58949e-05
|
|
|
DFNB3
|
[NCBI]
|
1.58949e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
1.58949e-05
|
|
|
hyperbilirubinemia, transient familial neonatal
|
[NCBI]
|
1.58949e-05
|
|
|
AK1
|
[NCBI]
|
1.58164e-05
|
|
|
CETP
|
[NCBI]
|
1.58164e-05
|
|
|
CMH
|
[NCBI]
|
1.5699e-05
|
|
|
MODY
|
[NCBI]
|
1.56096e-05
|
|
|
HCRTR2
|
[NCBI]
|
1.5432e-05
|
|
|
MTP
|
[NCBI]
|
1.5432e-05
|
|
|
TCF4
|
[NCBI]
|
1.5432e-05
|
|
|
HLA-C
|
[NCBI]
|
1.5432e-05
|
|
|
BLMH
|
[NCBI]
|
1.5432e-05
|
|
|
COL9A1
|
[NCBI]
|
1.5432e-05
|
|
|
ATXN2
|
[NCBI]
|
1.5432e-05
|
|
|
IL8
|
[NCBI]
|
1.53612e-05
|
|
|
RECQL3
|
[NCBI]
|
1.53612e-05
|
|
|
LCT
|
[NCBI]
|
1.50085e-05
|
|
|
SCA7
|
[NCBI]
|
1.49988e-05
|
|
|
TFPI
|
[NCBI]
|
1.49948e-05
|
|
|
TECTA
|
[NCBI]
|
1.46517e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.46517e-05
|
|
|
OGG1
|
[NCBI]
|
1.46517e-05
|
|
|
AHCY
|
[NCBI]
|
1.46517e-05
|
|
|
HABP2
|
[NCBI]
|
1.46517e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.46019e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.45008e-05
|
|
|
CBD
|
[NCBI]
|
1.45008e-05
|
|
|
CYP2A6
|
[NCBI]
|
1.40936e-05
|
|
|
IGKC
|
[NCBI]
|
1.40936e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.40756e-05
|
|
|
OPMD
|
[NCBI]
|
1.396e-05
|
|
|
DRD5
|
[NCBI]
|
1.39326e-05
|
|
|
APOA4
|
[NCBI]
|
1.39326e-05
|
|
|
CCKAR
|
[NCBI]
|
1.39326e-05
|
|
|
ALOX5AP
|
[NCBI]
|
1.39326e-05
|
|
|
CTNS
|
[NCBI]
|
1.39326e-05
|
|
|
NTF3
|
[NCBI]
|
1.39326e-05
|
|
|
FOXP2
|
[NCBI]
|
1.39326e-05
|
|
|
DFNA3
|
[NCBI]
|
1.39295e-05
|
|
|
HFE3
|
[NCBI]
|
1.39295e-05
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
1.39295e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
1.39295e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
1.39295e-05
|
|
|
AML
|
[NCBI]
|
1.39295e-05
|
|
|
CMT2D
|
[NCBI]
|
1.39295e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.38761e-05
|
|
|
RP1
|
[NCBI]
|
1.3855e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
1.3855e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
1.3855e-05
|
|
|
BCHE
|
[NCBI]
|
1.37011e-05
|
|
|
ABCC6
|
[NCBI]
|
1.37006e-05
|
|
|
MDM2
|
[NCBI]
|
1.37006e-05
|
|
|
PAI1
|
[NCBI]
|
1.37006e-05
|
|
|
BLM
|
[NCBI]
|
1.36446e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.36446e-05
|
|
|
IRS1
|
[NCBI]
|
1.3329e-05
|
|
|
ACADS
|
[NCBI]
|
1.3321e-05
|
|
|
FANCA
|
[NCBI]
|
1.3321e-05
|
|
|
ASPA
|
[NCBI]
|
1.3321e-05
|
|
|
AMY2A
|
[NCBI]
|
1.32667e-05
|
|
|
IRF6
|
[NCBI]
|
1.32667e-05
|
|
|
SELE
|
[NCBI]
|
1.32667e-05
|
|
|
CYP2C9
|
[NCBI]
|
1.32667e-05
|
|
|
ALOX5
|
[NCBI]
|
1.32667e-05
|
|
|
PLIN
|
[NCBI]
|
1.32667e-05
|
|
|
AMH
|
[NCBI]
|
1.32565e-05
|
|
|
MYOZ2
|
[NCBI]
|
1.3022e-05
|
|
|
PTGES2
|
[NCBI]
|
1.3022e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.3022e-05
|
|
|
IGLP1
|
[NCBI]
|
1.3022e-05
|
|
|
DMGDH
|
[NCBI]
|
1.3022e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
1.3022e-05
|
|
|
ERDA1
|
[NCBI]
|
1.3022e-05
|
|
|
IHG
|
[NCBI]
|
1.3022e-05
|
|
|
nebulette
|
[NCBI]
|
1.3022e-05
|
|
|
PCDHA8
|
[NCBI]
|
1.3022e-05
|
|
|
MAGED2
|
[NCBI]
|
1.3022e-05
|
|
|
BARX2
|
[NCBI]
|
1.3022e-05
|
|
|
DDX25
|
[NCBI]
|
1.3022e-05
|
|
|
PKDREJ
|
[NCBI]
|
1.3022e-05
|
|
|
PCDHA10
|
[NCBI]
|
1.3022e-05
|
|
|
RBM17
|
[NCBI]
|
1.3022e-05
|
|
|
ADH6
|
[NCBI]
|
1.3022e-05
|
|
|
TAAR9
|
[NCBI]
|
1.3022e-05
|
|
|
TNIP1
|
[NCBI]
|
1.3022e-05
|
|
|
AMPD3
|
[NCBI]
|
1.3022e-05
|
|
|
PPP1R3B
|
[NCBI]
|
1.3022e-05
|
|
|
CHL1
|
[NCBI]
|
1.3022e-05
|
|
|
PCSK4
|
[NCBI]
|
1.3022e-05
|
|
|
CYP2C18
|
[NCBI]
|
1.3022e-05
|
|
|
SLC6A19
|
[NCBI]
|
1.3022e-05
|
|
|
WNT5B
|
[NCBI]
|
1.3022e-05
|
|
|
CCL26
|
[NCBI]
|
1.3022e-05
|
|
|
PDCD8
|
[NCBI]
|
1.30117e-05
|
|
|
FANCC
|
[NCBI]
|
1.29541e-05
|
|
|
ABO
|
[NCBI]
|
1.29541e-05
|
|
|
HDC
|
[NCBI]
|
1.29302e-05
|
|
|
FA
|
[NCBI]
|
1.28832e-05
|
|
|
MIF
|
[NCBI]
|
1.26476e-05
|
|
|
CAST
|
[NCBI]
|
1.26476e-05
|
|
|
IL7R
|
[NCBI]
|
1.26476e-05
|
|
|
GJA4
|
[NCBI]
|
1.26476e-05
|
|
|
krabbe disease
|
[NCBI]
|
1.26058e-05
|
|
|
RHCE
|
[NCBI]
|
1.25993e-05
|
|
|
PDYN
|
[NCBI]
|
1.25993e-05
|
|
|
GPT
|
[NCBI]
|
1.25477e-05
|
|
|
CP
|
[NCBI]
|
1.25338e-05
|
|
|
CDK5
|
[NCBI]
|
1.22816e-05
|
|
|
SCN3
|
[NCBI]
|
1.22444e-05
|
|
|
CZP1
|
[NCBI]
|
1.22444e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
1.22444e-05
|
|
|
DFNB9
|
[NCBI]
|
1.22444e-05
|
|
|
aryl hydrocarbon hydroxylase inducibility
|
[NCBI]
|
1.22444e-05
|
|
|
hydrocephalus
|
[NCBI]
|
1.22444e-05
|
|
|
USH1D
|
[NCBI]
|
1.22444e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
1.22444e-05
|
|
|
PBT
|
[NCBI]
|
1.22444e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
1.22444e-05
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
1.21802e-05
|
|
|
SOD2
|
[NCBI]
|
1.21526e-05
|
|
|
SURF1
|
[NCBI]
|
1.20698e-05
|
|
|
BHMT
|
[NCBI]
|
1.20698e-05
|
|
|
SERPINA6
|
[NCBI]
|
1.20397e-05
|
|
|
WHS
|
[NCBI]
|
1.19421e-05
|
|
|
GAA
|
[NCBI]
|
1.19235e-05
|
|
|
INSR
|
[NCBI]
|
1.18441e-05
|
|
|
ACPP
|
[NCBI]
|
1.17185e-05
|
|
|
WT1
|
[NCBI]
|
1.16137e-05
|
|
|
TCRG
|
[NCBI]
|
1.16015e-05
|
|
|
RETN
|
[NCBI]
|
1.15289e-05
|
|
|
IRDN
|
[NCBI]
|
1.15289e-05
|
|
|
KCNE1
|
[NCBI]
|
1.15289e-05
|
|
|
FUT2
|
[NCBI]
|
1.15289e-05
|
|
|
HMOX1
|
[NCBI]
|
1.15289e-05
|
|
|
FCHL
|
[NCBI]
|
1.14112e-05
|
|
|
MKS1
|
[NCBI]
|
1.13921e-05
|
|
|
PXE
|
[NCBI]
|
1.13445e-05
|
|
|
HEXB
|
[NCBI]
|
1.12893e-05
|
|
|
AKR1B1
|
[NCBI]
|
1.12394e-05
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
1.11426e-05
|
|
|
PEX26
|
[NCBI]
|
1.11035e-05
|
|
|
COLEC12
|
[NCBI]
|
1.11035e-05
|
|
|
HOXD8
|
[NCBI]
|
1.11035e-05
|
|
|
CFHR5
|
[NCBI]
|
1.11035e-05
|
|
|
DNMBP
|
[NCBI]
|
1.11035e-05
|
|
|
TLR6
|
[NCBI]
|
1.11035e-05
|
|
|
PCSK5
|
[NCBI]
|
1.11035e-05
|
|
|
KRN1
|
[NCBI]
|
1.11035e-05
|
|
|
PLEKHG4
|
[NCBI]
|
1.11035e-05
|
|
|
CHGB
|
[NCBI]
|
1.11035e-05
|
|
|
TRIOBP
|
[NCBI]
|
1.11035e-05
|
|
|
ACTN2
|
[NCBI]
|
1.11035e-05
|
|
|
minor histocompatibility antigen ha-2
|
[NCBI]
|
1.11035e-05
|
|
|
BTBD9
|
[NCBI]
|
1.11035e-05
|
|
|
XYLT1
|
[NCBI]
|
1.11035e-05
|
|
|
APBB2
|
[NCBI]
|
1.11035e-05
|
|
|
TSNAX
|
[NCBI]
|
1.11035e-05
|
|
|
GSTM3
|
[NCBI]
|
1.11035e-05
|
|
|
IFNA17
|
[NCBI]
|
1.11035e-05
|
|
|
CFHR3
|
[NCBI]
|
1.11035e-05
|
|
|
LILRA3
|
[NCBI]
|
1.11035e-05
|
|
|
BACH2
|
[NCBI]
|
1.11035e-05
|
|
|
CTDP1
|
[NCBI]
|
1.11035e-05
|
|
|
PSMA6
|
[NCBI]
|
1.11035e-05
|
|
|
NPC1L1
|
[NCBI]
|
1.11035e-05
|
|
|
UBC
|
[NCBI]
|
1.11035e-05
|
|
|
PSMB8
|
[NCBI]
|
1.11035e-05
|
|
|
RRAD
|
[NCBI]
|
1.11035e-05
|
|
|
FGL2
|
[NCBI]
|
1.11035e-05
|
|
|
SRR
|
[NCBI]
|
1.11035e-05
|
|
|
GAPDHS
|
[NCBI]
|
1.11035e-05
|
|
|
KIR2DL5
|
[NCBI]
|
1.11035e-05
|
|
|
JRK
|
[NCBI]
|
1.11035e-05
|
|
|
GABRB1
|
[NCBI]
|
1.11035e-05
|
|
|
DHCR7
|
[NCBI]
|
1.10212e-05
|
|
|
IGHV
|
[NCBI]
|
1.10212e-05
|
|
|
SFTPB
|
[NCBI]
|
1.10212e-05
|
|
|
CYP2C19
|
[NCBI]
|
1.10212e-05
|
|
|
LCP1
|
[NCBI]
|
1.10212e-05
|
|
|
BCR
|
[NCBI]
|
1.09219e-05
|
|
|
SDC2
|
[NCBI]
|
1.08427e-05
|
|
|
ASMD
|
[NCBI]
|
1.07831e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
1.07831e-05
|
|
|
IFD
|
[NCBI]
|
1.07831e-05
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
1.07831e-05
|
|
|
SCZD2
|
[NCBI]
|
1.07831e-05
|
|
|
Ii
|
[NCBI]
|
1.07831e-05
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
1.07831e-05
|
|
|
scheie syndrome
|
[NCBI]
|
1.07831e-05
|
|
|
gracile syndrome
|
[NCBI]
|
1.07831e-05
|
|
|
CMT2A2
|
[NCBI]
|
1.07831e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
1.07831e-05
|
|
|
tyrosinemia, type i
|
[NCBI]
|
1.06929e-05
|
|
|
APS1
|
[NCBI]
|
1.06432e-05
|
|
|
GJB6
|
[NCBI]
|
1.05433e-05
|
|
|
ALPP
|
[NCBI]
|
1.05433e-05
|
|
|
CPT2
|
[NCBI]
|
1.05433e-05
|
|
|
RB1
|
[NCBI]
|
1.037e-05
|
|
|
HBG1
|
[NCBI]
|
1.02671e-05
|
|
|
PARP1
|
[NCBI]
|
1.02671e-05
|
|
|
PLOD1
|
[NCBI]
|
1.00925e-05
|
|
|
SELP
|
[NCBI]
|
1.00925e-05
|
|
|
ASIP
|
[NCBI]
|
1.00925e-05
|
|
|
MDD
|
[NCBI]
|
1.00278e-05
|
|
|
CMM
|
[NCBI]
|
9.94004e-06
|
|
|
TLR5
|
[NCBI]
|
9.86213e-06
|
|
|
MMP20
|
[NCBI]
|
9.70336e-06
|
|
|
PTGDR
|
[NCBI]
|
9.70336e-06
|
|
|
FOXE3
|
[NCBI]
|
9.70336e-06
|
|
|
PLA1A
|
[NCBI]
|
9.70336e-06
|
|
|
IL10RA
|
[NCBI]
|
9.70336e-06
|
|
|
RDH12
|
[NCBI]
|
9.70336e-06
|
|
|
CPT1B
|
[NCBI]
|
9.70336e-06
|
|
|
GDF9
|
[NCBI]
|
9.70336e-06
|
|
|
GLMN
|
[NCBI]
|
9.70336e-06
|
|
|
GPD1
|
[NCBI]
|
9.70336e-06
|
|
|
PCDHA9
|
[NCBI]
|
9.70336e-06
|
|
|
ADH7
|
[NCBI]
|
9.70336e-06
|
|
|
GNPTAB
|
[NCBI]
|
9.70336e-06
|
|
|
ABCC11
|
[NCBI]
|
9.70336e-06
|
|
|
NCR3
|
[NCBI]
|
9.70336e-06
|
|
|
TFCP2
|
[NCBI]
|
9.70336e-06
|
|
|
NFKBIL1
|
[NCBI]
|
9.70336e-06
|
|
|
BRSK2
|
[NCBI]
|
9.70336e-06
|
|
|
PTPN2
|
[NCBI]
|
9.70336e-06
|
|
|
RAD54L
|
[NCBI]
|
9.70336e-06
|
|
|
POSTN
|
[NCBI]
|
9.70336e-06
|
|
|
CYSLTR2
|
[NCBI]
|
9.70336e-06
|
|
|
ATG16L1
|
[NCBI]
|
9.70336e-06
|
|
|
CLN6
|
[NCBI]
|
9.70336e-06
|
|
|
MTUS1
|
[NCBI]
|
9.70336e-06
|
|
|
GANC
|
[NCBI]
|
9.70336e-06
|
|
|
saitohin
|
[NCBI]
|
9.70336e-06
|
|
|
EVC
|
[NCBI]
|
9.70336e-06
|
|
|
GPR74
|
[NCBI]
|
9.70336e-06
|
|
|
FADS1
|
[NCBI]
|
9.70336e-06
|
|
|
GIF
|
[NCBI]
|
9.70336e-06
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
9.70336e-06
|
|
|
HPA-2
|
[NCBI]
|
9.70336e-06
|
|
|
IRAK3
|
[NCBI]
|
9.70336e-06
|
|
|
LTC4S
|
[NCBI]
|
9.6663e-06
|
|
|
MSTN
|
[NCBI]
|
9.60085e-06
|
|
|
DFNA6
|
[NCBI]
|
9.50475e-06
|
|
|
THC1
|
[NCBI]
|
9.50475e-06
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
9.50475e-06
|
|
|
CMT4A
|
[NCBI]
|
9.50475e-06
|
|
|
SMA4
|
[NCBI]
|
9.50475e-06
|
|
|
MTC
|
[NCBI]
|
9.50475e-06
|
|
|
CLN5
|
[NCBI]
|
9.50475e-06
|
|
|
CMT2B
|
[NCBI]
|
9.50475e-06
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
9.50475e-06
|
|
|
medulloblastoma
|
[NCBI]
|
9.50475e-06
|
|
|
STAR
|
[NCBI]
|
9.44227e-06
|
|
|
RP
|
[NCBI]
|
9.38362e-06
|
|
|
TBG
|
[NCBI]
|
9.34686e-06
|
|
|
ZS
|
[NCBI]
|
9.30975e-06
|
|
|
factor v deficiency
|
[NCBI]
|
9.28498e-06
|
|
|
PGR
|
[NCBI]
|
9.26694e-06
|
|
|
PMM2
|
[NCBI]
|
9.26269e-06
|
|
|
CYP11B1
|
[NCBI]
|
9.26269e-06
|
|
|
PINK1
|
[NCBI]
|
9.26269e-06
|
|
|
KCNH2
|
[NCBI]
|
9.05131e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
9.04792e-06
|
|
|
porphyria variegata
|
[NCBI]
|
8.93296e-06
|
|
|
CLOCK
|
[NCBI]
|
8.87979e-06
|
|
|
EGR2
|
[NCBI]
|
8.87979e-06
|
|
|
IGHG1
|
[NCBI]
|
8.85964e-06
|
|
|
F13A1
|
[NCBI]
|
8.85964e-06
|
|
|
SCN5A
|
[NCBI]
|
8.85964e-06
|
|
|
CMTX1
|
[NCBI]
|
8.72853e-06
|
|
|
SMA3
|
[NCBI]
|
8.72853e-06
|
|
|
IL6
|
[NCBI]
|
8.72155e-06
|
|
|
PMD
|
[NCBI]
|
8.71961e-06
|
|
|
ALB
|
[NCBI]
|
8.70498e-06
|
|
|
FXN
|
[NCBI]
|
8.62587e-06
|
|
|
SLC2A10
|
[NCBI]
|
8.60855e-06
|
|
|
CLEC16A
|
[NCBI]
|
8.60855e-06
|
|
|
GFRA2
|
[NCBI]
|
8.60855e-06
|
|
|
BTNL2
|
[NCBI]
|
8.60855e-06
|
|
|
ANXA8
|
[NCBI]
|
8.60855e-06
|
|
|
SYNJ1
|
[NCBI]
|
8.60855e-06
|
|
|
GDA
|
[NCBI]
|
8.60855e-06
|
|
|
MYH8
|
[NCBI]
|
8.60855e-06
|
|
|
PLOD3
|
[NCBI]
|
8.60855e-06
|
|
|
SYN2
|
[NCBI]
|
8.60855e-06
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
8.60855e-06
|
|
|
CHRNB4
|
[NCBI]
|
8.60855e-06
|
|
|
COPA
|
[NCBI]
|
8.60855e-06
|
|
|
SH2B3
|
[NCBI]
|
8.60855e-06
|
|
|
KCNN3
|
[NCBI]
|
8.60855e-06
|
|
|
IGHA2
|
[NCBI]
|
8.60855e-06
|
|
|
UGT2B17
|
[NCBI]
|
8.60855e-06
|
|
|
CHE2
|
[NCBI]
|
8.60855e-06
|
|
|
COH1
|
[NCBI]
|
8.60855e-06
|
|
|
FUCA2
|
[NCBI]
|
8.60855e-06
|
|
|
NPY5R
|
[NCBI]
|
8.60855e-06
|
|
|
SLC9A3R1
|
[NCBI]
|
8.60855e-06
|
|
|
HSPA1L
|
[NCBI]
|
8.60855e-06
|
|
|
PLUNC
|
[NCBI]
|
8.60855e-06
|
|
|
CES2
|
[NCBI]
|
8.60855e-06
|
|
|
CASP12
|
[NCBI]
|
8.60855e-06
|
|
|
FKBP5
|
[NCBI]
|
8.60855e-06
|
|
|
MYO10
|
[NCBI]
|
8.60855e-06
|
|
|
KIR2DL2
|
[NCBI]
|
8.60855e-06
|
|
|
NOD1
|
[NCBI]
|
8.60855e-06
|
|
|
TACR2
|
[NCBI]
|
8.60855e-06
|
|
|
PLA2G1B
|
[NCBI]
|
8.60855e-06
|
|
|
MGP
|
[NCBI]
|
8.60855e-06
|
|
|
MLH3
|
[NCBI]
|
8.60855e-06
|
|
|
SESN1
|
[NCBI]
|
8.60855e-06
|
|
|
TCP1
|
[NCBI]
|
8.60855e-06
|
|
|
GABRA4
|
[NCBI]
|
8.60855e-06
|
|
|
KIF11
|
[NCBI]
|
8.60855e-06
|
|
|
CTSF
|
[NCBI]
|
8.60855e-06
|
|
|
RRM1
|
[NCBI]
|
8.60855e-06
|
|
|
KMO
|
[NCBI]
|
8.60855e-06
|
|
|
BBS1
|
[NCBI]
|
8.60855e-06
|
|
|
ANKK1
|
[NCBI]
|
8.60855e-06
|
|
|
DLG5
|
[NCBI]
|
8.60855e-06
|
|
|
SCN1A
|
[NCBI]
|
8.51598e-06
|
|
|
NRAS
|
[NCBI]
|
8.51598e-06
|
|
|
HPX
|
[NCBI]
|
8.51598e-06
|
|
|
UCP2
|
[NCBI]
|
8.5067e-06
|
|
|
MEN2A
|
[NCBI]
|
8.49277e-06
|
|
|
NM
|
[NCBI]
|
8.37879e-06
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
8.37879e-06
|
|
|
crouzon syndrome
|
[NCBI]
|
8.37879e-06
|
|
|
monilethrix
|
[NCBI]
|
8.37879e-06
|
|
|
FTNS
|
[NCBI]
|
8.37879e-06
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
8.37879e-06
|
|
|
autoimmune disease
|
[NCBI]
|
8.37879e-06
|
|
|
XPD
|
[NCBI]
|
8.37879e-06
|
|
|
OPPG
|
[NCBI]
|
8.37879e-06
|
|
|
CASR
|
[NCBI]
|
8.35501e-06
|
|
|
UCP3
|
[NCBI]
|
8.22265e-06
|
|
|
MSH2
|
[NCBI]
|
8.17685e-06
|
|
|
JMML
|
[NCBI]
|
8.17267e-06
|
|
|
ALDH1A1
|
[NCBI]
|
8.16982e-06
|
|
|
GJA5
|
[NCBI]
|
8.16982e-06
|
|
|
OPA1
|
[NCBI]
|
8.16982e-06
|
|
|
GSTM1
|
[NCBI]
|
8.16982e-06
|
|
|
MVK
|
[NCBI]
|
8.16982e-06
|
|
|
WRN
|
[NCBI]
|
7.87706e-06
|
|
|
ALK
|
[NCBI]
|
7.84179e-06
|
|
|
GAS
|
[NCBI]
|
7.84e-06
|
|
|
GNRHR
|
[NCBI]
|
7.75103e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
7.73402e-06
|
|
|
BRD2
|
[NCBI]
|
7.71546e-06
|
|
|
FBXO15
|
[NCBI]
|
7.71546e-06
|
|
|
CPN1
|
[NCBI]
|
7.71546e-06
|
|
|
DGCR14
|
[NCBI]
|
7.71546e-06
|
|
|
NHLH1
|
[NCBI]
|
7.71546e-06
|
|
|
MPP1
|
[NCBI]
|
7.71546e-06
|
|
|
SLC4A2
|
[NCBI]
|
7.71546e-06
|
|
|
PPARGC1B
|
[NCBI]
|
7.71546e-06
|
|
|
ADIPOR2
|
[NCBI]
|
7.71546e-06
|
|
|
MUC3A
|
[NCBI]
|
7.71546e-06
|
|
|
AIF1
|
[NCBI]
|
7.71546e-06
|
|
|
IGF2BP2
|
[NCBI]
|
7.71546e-06
|
|
|
DEK
|
[NCBI]
|
7.71546e-06
|
|
|
DPYSL2
|
[NCBI]
|
7.71546e-06
|
|
|
SLC30A8
|
[NCBI]
|
7.71546e-06
|
|
|
DYX1C1
|
[NCBI]
|
7.71546e-06
|
|
|
ADH4
|
[NCBI]
|
7.71546e-06
|
|
|
PTPNS1
|
[NCBI]
|
7.71546e-06
|
|
|
NHLRC1
|
[NCBI]
|
7.71546e-06
|
|
|
HLA-DPB1
|
[NCBI]
|
7.71546e-06
|
|
|
PRB2
|
[NCBI]
|
7.71546e-06
|
|
|
PCK1
|
[NCBI]
|
7.71546e-06
|
|
|
SORL1
|
[NCBI]
|
7.71546e-06
|
|
|
KCNA5
|
[NCBI]
|
7.71546e-06
|
|
|
P2RY12
|
[NCBI]
|
7.71546e-06
|
|
|
LMNB2
|
[NCBI]
|
7.71546e-06
|
|
|
UGT2B4
|
[NCBI]
|
7.71546e-06
|
|
|
FOXJ1
|
[NCBI]
|
7.71546e-06
|
|
|
SLC6A4
|
[NCBI]
|
7.70243e-06
|
|
|
GLC1A
|
[NCBI]
|
7.59218e-06
|
|
|
CTNS
|
[NCBI]
|
7.59218e-06
|
|
|
COL2A1
|
[NCBI]
|
7.57698e-06
|
|
|
SLC2A2
|
[NCBI]
|
7.54633e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
7.5254e-06
|
|
|
TNF
|
[NCBI]
|
7.51311e-06
|
|
|
HNF1A
|
[NCBI]
|
7.42275e-06
|
|
|
LGMD2I
|
[NCBI]
|
7.38168e-06
|
|
|
JME
|
[NCBI]
|
7.38168e-06
|
|
|
sitosterolemia
|
[NCBI]
|
7.38168e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
7.38168e-06
|
|
|
ISS
|
[NCBI]
|
7.38168e-06
|
|
|
PPS
|
[NCBI]
|
7.38168e-06
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
7.38168e-06
|
|
|
tetralogy of fallot
|
[NCBI]
|
7.38168e-06
|
|
|
LGMD1B
|
[NCBI]
|
7.38168e-06
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
7.38168e-06
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
7.38168e-06
|
|
|
HBD
|
[NCBI]
|
7.34684e-06
|
|
|
EPOR
|
[NCBI]
|
7.32348e-06
|
|
|
MPZ
|
[NCBI]
|
7.27128e-06
|
|
|
GCK
|
[NCBI]
|
7.27128e-06
|
|
|
SST
|
[NCBI]
|
7.25002e-06
|
|
|
GP1BA
|
[NCBI]
|
7.22496e-06
|
|
|
PROS1
|
[NCBI]
|
7.22496e-06
|
|
|
MMP9
|
[NCBI]
|
7.1524e-06
|
|
|
ABCG5
|
[NCBI]
|
6.96576e-06
|
|
|
IRGM
|
[NCBI]
|
6.96576e-06
|
|
|
CLCN4
|
[NCBI]
|
6.96576e-06
|
|
|
CCHCR1
|
[NCBI]
|
6.96576e-06
|
|
|
OPRK1
|
[NCBI]
|
6.96576e-06
|
|
|
FKBP1B
|
[NCBI]
|
6.96576e-06
|
|
|
TNFSF7
|
[NCBI]
|
6.96576e-06
|
|
|
ISL1
|
[NCBI]
|
6.96576e-06
|
|
|
IL8RA
|
[NCBI]
|
6.96576e-06
|
|
|
GPR154
|
[NCBI]
|
6.96576e-06
|
|
|
NT5C
|
[NCBI]
|
6.96576e-06
|
|
|
SRD5A1
|
[NCBI]
|
6.96576e-06
|
|
|
BMP5
|
[NCBI]
|
6.96576e-06
|
|
|
FUT6
|
[NCBI]
|
6.96576e-06
|
|
|
RPL7A
|
[NCBI]
|
6.96576e-06
|
|
|
AGRP
|
[NCBI]
|
6.96576e-06
|
|
|
DNASE2
|
[NCBI]
|
6.96576e-06
|
|
|
CHIT1
|
[NCBI]
|
6.96576e-06
|
|
|
PODXL
|
[NCBI]
|
6.96576e-06
|
|
|
CLDN14
|
[NCBI]
|
6.96576e-06
|
|
|
TAC1
|
[NCBI]
|
6.96576e-06
|
|
|
FSCN2
|
[NCBI]
|
6.96576e-06
|
|
|
KIF1B
|
[NCBI]
|
6.96576e-06
|
|
|
ACP2
|
[NCBI]
|
6.96576e-06
|
|
|
KRT4
|
[NCBI]
|
6.96576e-06
|
|
|
CNGA3
|
[NCBI]
|
6.96576e-06
|
|
|
PDXK
|
[NCBI]
|
6.96576e-06
|
|
|
MTND4
|
[NCBI]
|
6.96284e-06
|
|
|
ADH5
|
[NCBI]
|
6.93778e-06
|
|
|
RBP4
|
[NCBI]
|
6.93778e-06
|
|
|
KCNJ11
|
[NCBI]
|
6.93778e-06
|
|
|
IRS2
|
[NCBI]
|
6.93778e-06
|
|
|
PRODH
|
[NCBI]
|
6.93778e-06
|
|
|
PNMT
|
[NCBI]
|
6.92744e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
6.88619e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
6.88619e-06
|
|
|
OXT
|
[NCBI]
|
6.81245e-06
|
|
|
IGF1R
|
[NCBI]
|
6.66299e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
6.66299e-06
|
|
|
COL6A1
|
[NCBI]
|
6.66299e-06
|
|
|
MTRNR1
|
[NCBI]
|
6.66299e-06
|
|
|
CYP19A1
|
[NCBI]
|
6.59774e-06
|
|
|
esophageal cancer
|
[NCBI]
|
6.49496e-06
|
|
|
ADLTE
|
[NCBI]
|
6.49496e-06
|
|
|
nondisjunction
|
[NCBI]
|
6.49496e-06
|
|
|
gilbert syndrome
|
[NCBI]
|
6.49496e-06
|
|
|
SCZD4
|
[NCBI]
|
6.49496e-06
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
6.49496e-06
|
|
|
propionic acidemia
|
[NCBI]
|
6.49496e-06
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
6.49496e-06
|
|
|
complement factor h deficiency
|
[NCBI]
|
6.49496e-06
|
|
|
danon disease
|
[NCBI]
|
6.49496e-06
|
|
|
SOST
|
[NCBI]
|
6.49496e-06
|
|
|
MN
|
[NCBI]
|
6.39984e-06
|
|
|
CYP1A1
|
[NCBI]
|
6.34199e-06
|
|
|
ABCG8
|
[NCBI]
|
6.32326e-06
|
|
|
FGF20
|
[NCBI]
|
6.32326e-06
|
|
|
AZGP1
|
[NCBI]
|
6.32326e-06
|
|
|
GAB2
|
[NCBI]
|
6.32326e-06
|
|
|
PEPB
|
[NCBI]
|
6.32326e-06
|
|
|
CYP3A7
|
[NCBI]
|
6.32326e-06
|
|
|
GCLM
|
[NCBI]
|
6.32326e-06
|
|
|
BDKRB2
|
[NCBI]
|
6.32326e-06
|
|
|
NEUROG3
|
[NCBI]
|
6.32326e-06
|
|
|
PDE11A
|
[NCBI]
|
6.32326e-06
|
|
|
CFHR1
|
[NCBI]
|
6.32326e-06
|
|
|
AHI1
|
[NCBI]
|
6.32326e-06
|
|
|
SCGB3A2
|
[NCBI]
|
6.32326e-06
|
|
|
BCKDHB
|
[NCBI]
|
6.32326e-06
|
|
|
CITED2
|
[NCBI]
|
6.32326e-06
|
|
|
NTS
|
[NCBI]
|
6.32326e-06
|
|
|
ABCA2
|
[NCBI]
|
6.32326e-06
|
|
|
CHRND
|
[NCBI]
|
6.32326e-06
|
|
|
HBQ1
|
[NCBI]
|
6.32326e-06
|
|
|
PTF1A
|
[NCBI]
|
6.32326e-06
|
|
|
SDC3
|
[NCBI]
|
6.32326e-06
|
|
|
CACNB4
|
[NCBI]
|
6.32326e-06
|
|
|
FCAR
|
[NCBI]
|
6.32326e-06
|
|
|
DNASE1
|
[NCBI]
|
6.32326e-06
|
|
|
FRZB
|
[NCBI]
|
6.32326e-06
|
|
|
PRLR
|
[NCBI]
|
6.28339e-06
|
|
|
IL4
|
[NCBI]
|
6.28339e-06
|
|
|
CCD
|
[NCBI]
|
6.17306e-06
|
|
|
CFI
|
[NCBI]
|
6.14763e-06
|
|
|
RHO
|
[NCBI]
|
6.14265e-06
|
|
|
ADM
|
[NCBI]
|
6.13519e-06
|
|
|
BMD
|
[NCBI]
|
6.10397e-06
|
|
|
TGFB1
|
[NCBI]
|
6.08299e-06
|
|
|
IAPP
|
[NCBI]
|
6.07533e-06
|
|
|
IDE
|
[NCBI]
|
6.02288e-06
|
|
|
PCD
|
[NCBI]
|
5.95498e-06
|
|
|
HEMB
|
[NCBI]
|
5.93072e-06
|
|
|
GCCR
|
[NCBI]
|
5.91965e-06
|
|
|
PPOX
|
[NCBI]
|
5.90573e-06
|
|
|
PD
|
[NCBI]
|
5.89327e-06
|
|
|
TYK2
|
[NCBI]
|
5.76397e-06
|
|
|
GSTT1
|
[NCBI]
|
5.76397e-06
|
|
|
RP1
|
[NCBI]
|
5.76397e-06
|
|
|
IL9R
|
[NCBI]
|
5.76397e-06
|
|
|
ERBB3
|
[NCBI]
|
5.76397e-06
|
|
|
CCL11
|
[NCBI]
|
5.76397e-06
|
|
|
CNGB3
|
[NCBI]
|
5.76397e-06
|
|
|
CTSG
|
[NCBI]
|
5.76397e-06
|
|
|
HBE1
|
[NCBI]
|
5.76397e-06
|
|
|
ATP8B1
|
[NCBI]
|
5.76397e-06
|
|
|
LITAF
|
[NCBI]
|
5.76397e-06
|
|
|
ITIH1
|
[NCBI]
|
5.76397e-06
|
|
|
TNFRSF13C
|
[NCBI]
|
5.76397e-06
|
|
|
MBD4
|
[NCBI]
|
5.76397e-06
|
|
|
BMP6
|
[NCBI]
|
5.76397e-06
|
|
|
AIP
|
[NCBI]
|
5.76397e-06
|
|
|
PRKG1
|
[NCBI]
|
5.76397e-06
|
|
|
PSMB9
|
[NCBI]
|
5.76397e-06
|
|
|
GCNT2
|
[NCBI]
|
5.76397e-06
|
|
|
CD3E
|
[NCBI]
|
5.76397e-06
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
5.70388e-06
|
|
|
hartnup disorder
|
[NCBI]
|
5.70388e-06
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
5.70388e-06
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
5.70388e-06
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
5.70388e-06
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
5.70388e-06
|
|
|
alexander disease
|
[NCBI]
|
5.70388e-06
|
|
|
IVA
|
[NCBI]
|
5.70388e-06
|
|
|
EPHX1
|
[NCBI]
|
5.67356e-06
|
|
|
IL13
|
[NCBI]
|
5.67356e-06
|
|
|
OA1
|
[NCBI]
|
5.67356e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
5.63379e-06
|
|
|
SDS
|
[NCBI]
|
5.63379e-06
|
|
|
CPB2
|
[NCBI]
|
5.52846e-06
|
|
|
PAX3
|
[NCBI]
|
5.45271e-06
|
|
|
MYO7A
|
[NCBI]
|
5.45057e-06
|
|
|
PG
|
[NCBI]
|
5.41015e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
5.37e-06
|
|
|
SLC1A5
|
[NCBI]
|
5.27117e-06
|
|
|
RPA1
|
[NCBI]
|
5.27117e-06
|
|
|
SLC17A5
|
[NCBI]
|
5.27117e-06
|
|
|
RGS4
|
[NCBI]
|
5.27117e-06
|
|
|
DEFB1
|
[NCBI]
|
5.27117e-06
|
|
|
MDM1
|
[NCBI]
|
5.27117e-06
|
|
|
DAP3
|
[NCBI]
|
5.27117e-06
|
|
|
SEMA3B
|
[NCBI]
|
5.27117e-06
|
|
|
AAAS
|
[NCBI]
|
5.27117e-06
|
|
|
PRKAA2
|
[NCBI]
|
5.27117e-06
|
|
|
SGCB
|
[NCBI]
|
5.27117e-06
|
|
|
LAMC1
|
[NCBI]
|
5.27117e-06
|
|
|
SORD
|
[NCBI]
|
5.27117e-06
|
|
|
HK2
|
[NCBI]
|
5.27117e-06
|
|
|
NRXN1
|
[NCBI]
|
5.27117e-06
|
|
|
KCNMB1
|
[NCBI]
|
5.27117e-06
|
|
|
ALPI
|
[NCBI]
|
5.27117e-06
|
|
|
GAS6
|
[NCBI]
|
5.27117e-06
|
|
|
ESR2
|
[NCBI]
|
5.23629e-06
|
|
|
CYP3A4
|
[NCBI]
|
5.23629e-06
|
|
|
HMBS
|
[NCBI]
|
5.22328e-06
|
|
|
MC4R
|
[NCBI]
|
5.15956e-06
|
|
|
LCAT
|
[NCBI]
|
5.04595e-06
|
|
|
PEMT
|
[NCBI]
|
5.03026e-06
|
|
|
wolman disease
|
[NCBI]
|
5.03026e-06
|
|
|
ADRB2
|
[NCBI]
|
5.03026e-06
|
|
|
DYX2
|
[NCBI]
|
4.99646e-06
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
4.99646e-06
|
|
|
DYT3
|
[NCBI]
|
4.99646e-06
|
|
|
DHRD
|
[NCBI]
|
4.99646e-06
|
|
|
NPHS1
|
[NCBI]
|
4.99646e-06
|
|
|
EDC
|
[NCBI]
|
4.99646e-06
|
|
|
blood group, p system
|
[NCBI]
|
4.99646e-06
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
4.99646e-06
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
4.99646e-06
|
|
|
acromegaly
|
[NCBI]
|
4.99646e-06
|
|
|
SPCH1
|
[NCBI]
|
4.99646e-06
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
4.99646e-06
|
|
|
lipomatosis, multiple
|
[NCBI]
|
4.95143e-06
|
|
|
HBFQTL2
|
[NCBI]
|
4.95143e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
4.8898e-06
|
|
|
SLC4A1
|
[NCBI]
|
4.88e-06
|
|
|
PLTP
|
[NCBI]
|
4.85278e-06
|
|
|
CRHR2
|
[NCBI]
|
4.83269e-06
|
|
|
CYP7A1
|
[NCBI]
|
4.83269e-06
|
|
|
ERCC8
|
[NCBI]
|
4.83269e-06
|
|
|
EIF2AK3
|
[NCBI]
|
4.83269e-06
|
|
|
FMN
|
[NCBI]
|
4.83269e-06
|
|
|
BRIP1
|
[NCBI]
|
4.83269e-06
|
|
|
GNPAT
|
[NCBI]
|
4.83269e-06
|
|
|
CKM
|
[NCBI]
|
4.83269e-06
|
|
|
NLRP3
|
[NCBI]
|
4.83269e-06
|
|
|
MATN1
|
[NCBI]
|
4.83269e-06
|
|
|
FLCN
|
[NCBI]
|
4.83269e-06
|
|
|
KIR2DL1
|
[NCBI]
|
4.83269e-06
|
|
|
CCR3
|
[NCBI]
|
4.83269e-06
|
|
|
UBQLN1
|
[NCBI]
|
4.83269e-06
|
|
|
MYF5
|
[NCBI]
|
4.83269e-06
|
|
|
SOST
|
[NCBI]
|
4.83269e-06
|
|
|
DGAT1
|
[NCBI]
|
4.83269e-06
|
|
|
TRIM24
|
[NCBI]
|
4.83269e-06
|
|
|
ITPA
|
[NCBI]
|
4.83269e-06
|
|
|
MS4A2
|
[NCBI]
|
4.83269e-06
|
|
|
MEIS1
|
[NCBI]
|
4.83269e-06
|
|
|
GRN
|
[NCBI]
|
4.6413e-06
|
|
|
AVSD
|
[NCBI]
|
4.60331e-06
|
|
|
ALS1
|
[NCBI]
|
4.60331e-06
|
|
|
SLC2A4
|
[NCBI]
|
4.51933e-06
|
|
|
RYR1
|
[NCBI]
|
4.4846e-06
|
|
|
sotos syndrome
|
[NCBI]
|
4.46616e-06
|
|
|
MATN3
|
[NCBI]
|
4.43946e-06
|
|
|
FCGR2B
|
[NCBI]
|
4.43946e-06
|
|
|
WWOX
|
[NCBI]
|
4.43946e-06
|
|
|
FKTN
|
[NCBI]
|
4.43946e-06
|
|
|
SULT1A1
|
[NCBI]
|
4.43946e-06
|
|
|
KRT8
|
[NCBI]
|
4.43946e-06
|
|
|
OLIG2
|
[NCBI]
|
4.43946e-06
|
|
|
APOC1
|
[NCBI]
|
4.43946e-06
|
|
|
PRKAG2
|
[NCBI]
|
4.43946e-06
|
|
|
CDC25A
|
[NCBI]
|
4.43946e-06
|
|
|
LTA4H
|
[NCBI]
|
4.43946e-06
|
|
|
ADD1
|
[NCBI]
|
4.43946e-06
|
|
|
ICOS
|
[NCBI]
|
4.43946e-06
|
|
|
HHEX
|
[NCBI]
|
4.43946e-06
|
|
|
CNTFR
|
[NCBI]
|
4.43946e-06
|
|
|
TREX1
|
[NCBI]
|
4.43946e-06
|
|
|
NDRG1
|
[NCBI]
|
4.43946e-06
|
|
|
OFD1
|
[NCBI]
|
4.36285e-06
|
|
|
bladder cancer
|
[NCBI]
|
4.36285e-06
|
|
|
FTLDU
|
[NCBI]
|
4.36285e-06
|
|
|
pituitary dwarfism i
|
[NCBI]
|
4.36285e-06
|
|
|
TTR
|
[NCBI]
|
4.30138e-06
|
|
|
TFR2
|
[NCBI]
|
4.28071e-06
|
|
|
ABCA4
|
[NCBI]
|
4.28071e-06
|
|
|
MMP3
|
[NCBI]
|
4.28071e-06
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
4.28071e-06
|
|
|
PTEN
|
[NCBI]
|
4.25672e-06
|
|
|
SLE
|
[NCBI]
|
4.12425e-06
|
|
|
GLA
|
[NCBI]
|
4.11023e-06
|
|
|
HOXB5
|
[NCBI]
|
4.08449e-06
|
|
|
DAZL
|
[NCBI]
|
4.08449e-06
|
|
|
CPT1A
|
[NCBI]
|
4.08449e-06
|
|
|
FLI1
|
[NCBI]
|
4.08449e-06
|
|
|
RAI1
|
[NCBI]
|
4.08449e-06
|
|
|
OLR1
|
[NCBI]
|
4.08449e-06
|
|
|
MTHFD1
|
[NCBI]
|
4.08449e-06
|
|
|
PEPA
|
[NCBI]
|
4.08449e-06
|
|
|
HLCS
|
[NCBI]
|
4.08449e-06
|
|
|
ATP1A1
|
[NCBI]
|
4.08449e-06
|
|
|
CALCR
|
[NCBI]
|
4.08449e-06
|
|
|
DRD1
|
[NCBI]
|
4.08449e-06
|
|
|
TFF2
|
[NCBI]
|
4.08449e-06
|
|
|
CBP2
|
[NCBI]
|
4.08449e-06
|
|
|
HGD
|
[NCBI]
|
4.08449e-06
|
|
|
ZP3
|
[NCBI]
|
4.08449e-06
|
|
|
XG
|
[NCBI]
|
4.08449e-06
|
|
|
ABCB4
|
[NCBI]
|
4.08449e-06
|
|
|
EBI3
|
[NCBI]
|
4.08449e-06
|
|
|
TYMS
|
[NCBI]
|
4.06989e-06
|
|
|
ATM
|
[NCBI]
|
4.04533e-06
|
|
|
PPARA
|
[NCBI]
|
4.03147e-06
|
|
|
PKD1
|
[NCBI]
|
3.95254e-06
|
|
|
POLG
|
[NCBI]
|
3.9459e-06
|
|
|
BGLAP
|
[NCBI]
|
3.80664e-06
|
|
|
HIDS
|
[NCBI]
|
3.79481e-06
|
|
|
HNA
|
[NCBI]
|
3.79481e-06
|
|
|
CBAVD
|
[NCBI]
|
3.79481e-06
|
|
|
IBM2
|
[NCBI]
|
3.79481e-06
|
|
|
bethlem myopathy
|
[NCBI]
|
3.79481e-06
|
|
|
RUNX1
|
[NCBI]
|
3.78746e-06
|
|
|
GSR
|
[NCBI]
|
3.78746e-06
|
|
|
ACH
|
[NCBI]
|
3.76759e-06
|
|
|
SLC22A1
|
[NCBI]
|
3.7623e-06
|
|
|
CD14
|
[NCBI]
|
3.7623e-06
|
|
|
EPM2A
|
[NCBI]
|
3.7623e-06
|
|
|
TBXA2R
|
[NCBI]
|
3.7623e-06
|
|
|
RNR1
|
[NCBI]
|
3.7623e-06
|
|
|
PFKL
|
[NCBI]
|
3.7623e-06
|
|
|
GGH
|
[NCBI]
|
3.7623e-06
|
|
|
ACO1
|
[NCBI]
|
3.7623e-06
|
|
|
NOTCH3
|
[NCBI]
|
3.7623e-06
|
|
|
P2RX7
|
[NCBI]
|
3.7623e-06
|
|
|
SLCO2A1
|
[NCBI]
|
3.7623e-06
|
|
|
NEFH
|
[NCBI]
|
3.7623e-06
|
|
|
LU
|
[NCBI]
|
3.7623e-06
|
|
|
APOC3
|
[NCBI]
|
3.7623e-06
|
|
|
BTD
|
[NCBI]
|
3.7623e-06
|
|
|
MAPT
|
[NCBI]
|
3.68369e-06
|
|
|
SRS
|
[NCBI]
|
3.67459e-06
|
|
|
LPI
|
[NCBI]
|
3.64343e-06
|
|
|
ND
|
[NCBI]
|
3.64343e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
3.64343e-06
|
|
|
CCND1
|
[NCBI]
|
3.59715e-06
|
|
|
FSHMD1A
|
[NCBI]
|
3.58244e-06
|
|
|
ASS
|
[NCBI]
|
3.55589e-06
|
|
|
LDHC
|
[NCBI]
|
3.46851e-06
|
|
|
NAGLU
|
[NCBI]
|
3.46851e-06
|
|
|
OTOF
|
[NCBI]
|
3.46851e-06
|
|
|
LIG4
|
[NCBI]
|
3.46851e-06
|
|
|
SOCS2
|
[NCBI]
|
3.46851e-06
|
|
|
MMP13
|
[NCBI]
|
3.46851e-06
|
|
|
HPSE
|
[NCBI]
|
3.46851e-06
|
|
|
SPG3A
|
[NCBI]
|
3.46851e-06
|
|
|
APOA2
|
[NCBI]
|
3.46851e-06
|
|
|
AGL
|
[NCBI]
|
3.46851e-06
|
|
|
TAP1
|
[NCBI]
|
3.46851e-06
|
|
|
PLAU
|
[NCBI]
|
3.46851e-06
|
|
|
PGK2
|
[NCBI]
|
3.46851e-06
|
|
|
COCH
|
[NCBI]
|
3.46851e-06
|
|
|
SDHB
|
[NCBI]
|
3.46851e-06
|
|
|
oncogene dj1
|
[NCBI]
|
3.46851e-06
|
|
|
VHL
|
[NCBI]
|
3.45144e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.41553e-06
|
|
|
hemophilia a
|
[NCBI]
|
3.40711e-06
|
|
|
FTD
|
[NCBI]
|
3.37688e-06
|
|
|
LS
|
[NCBI]
|
3.31863e-06
|
|
|
canavan disease
|
[NCBI]
|
3.28546e-06
|
|
|
KTCN1
|
[NCBI]
|
3.28546e-06
|
|
|
JAK2
|
[NCBI]
|
3.26252e-06
|
|
|
KDR
|
[NCBI]
|
3.24737e-06
|
|
|
AANAT
|
[NCBI]
|
3.20764e-06
|
|
|
NFKBIA
|
[NCBI]
|
3.19956e-06
|
|
|
COL18A1
|
[NCBI]
|
3.19956e-06
|
|
|
PANK2
|
[NCBI]
|
3.19956e-06
|
|
|
PRKCA
|
[NCBI]
|
3.19956e-06
|
|
|
CDC25C
|
[NCBI]
|
3.19956e-06
|
|
|
ADRB1
|
[NCBI]
|
3.19956e-06
|
|
|
LHX3
|
[NCBI]
|
3.19956e-06
|
|
|
NPHS1
|
[NCBI]
|
3.19956e-06
|
|
|
THBD
|
[NCBI]
|
3.19956e-06
|
|
|
LRAT
|
[NCBI]
|
3.19956e-06
|
|
|
ATXN3
|
[NCBI]
|
3.19956e-06
|
|
|
FST
|
[NCBI]
|
3.19956e-06
|
|
|
CNR1
|
[NCBI]
|
3.19956e-06
|
|
|
RAPSN
|
[NCBI]
|
3.19956e-06
|
|
|
ATP1A2
|
[NCBI]
|
3.19956e-06
|
|
|
SCARB1
|
[NCBI]
|
3.19956e-06
|
|
|
TLR1
|
[NCBI]
|
3.19956e-06
|
|
|
COL5A1
|
[NCBI]
|
3.19956e-06
|
|
|
CYBA
|
[NCBI]
|
3.19956e-06
|
|
|
NCF1
|
[NCBI]
|
3.19956e-06
|
|
|
PRTN3
|
[NCBI]
|
3.19956e-06
|
|
|
TPH1
|
[NCBI]
|
3.19956e-06
|
|
|
SLC19A1
|
[NCBI]
|
3.19956e-06
|
|
|
GPR24
|
[NCBI]
|
3.19956e-06
|
|
|
CHH
|
[NCBI]
|
3.19277e-06
|
|
|
HBA2
|
[NCBI]
|
3.1865e-06
|
|
|
NP
|
[NCBI]
|
3.07511e-06
|
|
|
RP2
|
[NCBI]
|
3.07511e-06
|
|
|
AIS
|
[NCBI]
|
2.97769e-06
|
|
|
COL1A2
|
[NCBI]
|
2.96393e-06
|
|
|
NR1I2
|
[NCBI]
|
2.95567e-06
|
|
|
APOM
|
[NCBI]
|
2.95252e-06
|
|
|
KCNQ1OT1
|
[NCBI]
|
2.95252e-06
|
|
|
ANGPTL4
|
[NCBI]
|
2.95252e-06
|
|
|
CBR1
|
[NCBI]
|
2.95252e-06
|
|
|
MYO6
|
[NCBI]
|
2.95252e-06
|
|
|
CRYBA1
|
[NCBI]
|
2.95252e-06
|
|
|
KEL
|
[NCBI]
|
2.95252e-06
|
|
|
SLC22A8
|
[NCBI]
|
2.95252e-06
|
|
|
CYP11A1
|
[NCBI]
|
2.95252e-06
|
|
|
NSD1
|
[NCBI]
|
2.95252e-06
|
|
|
FGB
|
[NCBI]
|
2.95252e-06
|
|
|
OCP
|
[NCBI]
|
2.88038e-06
|
|
|
GLC3A
|
[NCBI]
|
2.8289e-06
|
|
|
CGL2
|
[NCBI]
|
2.8289e-06
|
|
|
EDMD2
|
[NCBI]
|
2.8289e-06
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
2.8289e-06
|
|
|
pfeiffer syndrome
|
[NCBI]
|
2.8289e-06
|
|
|
APL
|
[NCBI]
|
2.8289e-06
|
|
|
SCA17
|
[NCBI]
|
2.8289e-06
|
|
|
DDC
|
[NCBI]
|
2.73932e-06
|
|
|
PFKM
|
[NCBI]
|
2.72496e-06
|
|
|
UCHL1
|
[NCBI]
|
2.72496e-06
|
|
|
NEFL
|
[NCBI]
|
2.72496e-06
|
|
|
ALDOA
|
[NCBI]
|
2.72496e-06
|
|
|
VCAM1
|
[NCBI]
|
2.72496e-06
|
|
|
PTS
|
[NCBI]
|
2.72496e-06
|
|
|
TRHR
|
[NCBI]
|
2.72496e-06
|
|
|
HBZ
|
[NCBI]
|
2.72496e-06
|
|
|
Ge
|
[NCBI]
|
2.72496e-06
|
|
|
JK
|
[NCBI]
|
2.72496e-06
|
|
|
TSHB
|
[NCBI]
|
2.72496e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
2.69742e-06
|
|
|
WS1
|
[NCBI]
|
2.6163e-06
|
|
|
homocystinuria
|
[NCBI]
|
2.61264e-06
|
|
|
von willebrand disease
|
[NCBI]
|
2.59741e-06
|
|
|
LHCGR
|
[NCBI]
|
2.58903e-06
|
|
|
OPRM1
|
[NCBI]
|
2.52982e-06
|
|
|
ACTC1
|
[NCBI]
|
2.51482e-06
|
|
|
FGF9
|
[NCBI]
|
2.51482e-06
|
|
|
NR4A2
|
[NCBI]
|
2.51482e-06
|
|
|
IL9
|
[NCBI]
|
2.51482e-06
|
|
|
XRCC9
|
[NCBI]
|
2.51482e-06
|
|
|
SGCE
|
[NCBI]
|
2.51482e-06
|
|
|
FRAXE
|
[NCBI]
|
2.51482e-06
|
|
|
SPR
|
[NCBI]
|
2.51482e-06
|
|
|
GUCY2D
|
[NCBI]
|
2.51482e-06
|
|
|
PCCB
|
[NCBI]
|
2.51482e-06
|
|
|
OTC
|
[NCBI]
|
2.47773e-06
|
|
|
SPINK1
|
[NCBI]
|
2.42733e-06
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
2.42011e-06
|
|
|
sialuria, finnish type
|
[NCBI]
|
2.42011e-06
|
|
|
mucolipidosis iv
|
[NCBI]
|
2.42011e-06
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
2.42011e-06
|
|
|
PLP1
|
[NCBI]
|
2.37023e-06
|
|
|
HOS
|
[NCBI]
|
2.35659e-06
|
|
|
INS
|
[NCBI]
|
2.32188e-06
|
|
|
CA2
|
[NCBI]
|
2.32035e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
2.32035e-06
|
|
|
CYGB
|
[NCBI]
|
2.32035e-06
|
|
|
DBT
|
[NCBI]
|
2.32035e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
2.32035e-06
|
|
|
DFFB
|
[NCBI]
|
2.26639e-06
|
|
|
REN
|
[NCBI]
|
2.26639e-06
|
|
|
SHFM1
|
[NCBI]
|
2.26547e-06
|
|
|
HBA1
|
[NCBI]
|
2.19372e-06
|
|
|
IGF2
|
[NCBI]
|
2.16609e-06
|
|
|
UCN
|
[NCBI]
|
2.15137e-06
|
|
|
SLC2A1
|
[NCBI]
|
2.14007e-06
|
|
|
GPR54
|
[NCBI]
|
2.14007e-06
|
|
|
FLT3
|
[NCBI]
|
2.14007e-06
|
|
|
DCX
|
[NCBI]
|
2.14007e-06
|
|
|
ITGB1
|
[NCBI]
|
2.14007e-06
|
|
|
HLA-G
|
[NCBI]
|
2.14007e-06
|
|
|
MG
|
[NCBI]
|
2.08986e-06
|
|
|
LMNA
|
[NCBI]
|
2.07184e-06
|
|
|
sudden infant death syndrome
|
[NCBI]
|
2.05474e-06
|
|
|
PAM
|
[NCBI]
|
2.04377e-06
|
|
|
RNASE2
|
[NCBI]
|
2.04377e-06
|
|
|
AGER
|
[NCBI]
|
2.03548e-06
|
|
|
SCD
|
[NCBI]
|
2.00166e-06
|
|
|
VHL
|
[NCBI]
|
1.98387e-06
|
|
|
IGF1
|
[NCBI]
|
1.97564e-06
|
|
|
KCNQ1
|
[NCBI]
|
1.97564e-06
|
|
|
GHSR
|
[NCBI]
|
1.97269e-06
|
|
|
MPL
|
[NCBI]
|
1.97269e-06
|
|
|
AMPD1
|
[NCBI]
|
1.97269e-06
|
|
|
CHM
|
[NCBI]
|
1.91787e-06
|
|
|
KRAS
|
[NCBI]
|
1.88526e-06
|
|
|
ALPS
|
[NCBI]
|
1.84477e-06
|
|
|
FGFR3
|
[NCBI]
|
1.82665e-06
|
|
|
VAMP2
|
[NCBI]
|
1.81707e-06
|
|
|
SDHD
|
[NCBI]
|
1.81707e-06
|
|
|
RHD
|
[NCBI]
|
1.81707e-06
|
|
|
CYP1B1
|
[NCBI]
|
1.81707e-06
|
|
|
LAMB3
|
[NCBI]
|
1.81707e-06
|
|
|
CASP8
|
[NCBI]
|
1.81707e-06
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
1.79799e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.77745e-06
|
|
|
IFNA1
|
[NCBI]
|
1.73121e-06
|
|
|
CMM2
|
[NCBI]
|
1.72901e-06
|
|
|
HOKPP
|
[NCBI]
|
1.72901e-06
|
|
|
glycogen storage disease v
|
[NCBI]
|
1.72901e-06
|
|
|
NPC1
|
[NCBI]
|
1.71437e-06
|
|
|
SLS
|
[NCBI]
|
1.71437e-06
|
|
|
PIGR
|
[NCBI]
|
1.67514e-06
|
|
|
MFN2
|
[NCBI]
|
1.67224e-06
|
|
|
CDH23
|
[NCBI]
|
1.67224e-06
|
|
|
LDHA
|
[NCBI]
|
1.67224e-06
|
|
|
CRYAA
|
[NCBI]
|
1.67224e-06
|
|
|
MTND3
|
[NCBI]
|
1.67224e-06
|
|
|
TK1
|
[NCBI]
|
1.67224e-06
|
|
|
CALCRL
|
[NCBI]
|
1.63064e-06
|
|
|
VWS
|
[NCBI]
|
1.61773e-06
|
|
|
FKRP
|
[NCBI]
|
1.53733e-06
|
|
|
MMP1
|
[NCBI]
|
1.53733e-06
|
|
|
CRP
|
[NCBI]
|
1.53733e-06
|
|
|
SRD5A2
|
[NCBI]
|
1.53733e-06
|
|
|
DFFA
|
[NCBI]
|
1.53733e-06
|
|
|
PCOS1
|
[NCBI]
|
1.50707e-06
|
|
|
PCI
|
[NCBI]
|
1.44143e-06
|
|
|
MELAS
|
[NCBI]
|
1.43961e-06
|
|
|
citrullinemia, classic
|
[NCBI]
|
1.43961e-06
|
|
|
PDB
|
[NCBI]
|
1.43961e-06
|
|
|
GUSB
|
[NCBI]
|
1.43532e-06
|
|
|
MTND2
|
[NCBI]
|
1.41159e-06
|
|
|
LYZ
|
[NCBI]
|
1.41159e-06
|
|
|
EXT1
|
[NCBI]
|
1.41159e-06
|
|
|
RBP3
|
[NCBI]
|
1.41159e-06
|
|
|
SLN
|
[NCBI]
|
1.41159e-06
|
|
|
CACNA1C
|
[NCBI]
|
1.41159e-06
|
|
|
pta deficiency
|
[NCBI]
|
1.41159e-06
|
|
|
GNAS
|
[NCBI]
|
1.38775e-06
|
|
|
FBN1
|
[NCBI]
|
1.38659e-06
|
|
|
ARMD1
|
[NCBI]
|
1.34814e-06
|
|
|
fabry disease
|
[NCBI]
|
1.34112e-06
|
|
|
CTNNB1
|
[NCBI]
|
1.33421e-06
|
|
|
CRYAB
|
[NCBI]
|
1.29432e-06
|
|
|
CTSK
|
[NCBI]
|
1.29432e-06
|
|
|
TSG101
|
[NCBI]
|
1.29432e-06
|
|
|
LRP8
|
[NCBI]
|
1.29432e-06
|
|
|
CD4
|
[NCBI]
|
1.29432e-06
|
|
|
ATF6
|
[NCBI]
|
1.29432e-06
|
|
|
RPS6
|
[NCBI]
|
1.29432e-06
|
|
|
ARPKD
|
[NCBI]
|
1.28938e-06
|
|
|
APOD
|
[NCBI]
|
1.26612e-06
|
|
|
ABCG2
|
[NCBI]
|
1.26497e-06
|
|
|
ANG
|
[NCBI]
|
1.20045e-06
|
|
|
IVD
|
[NCBI]
|
1.18493e-06
|
|
|
CHRNE
|
[NCBI]
|
1.18493e-06
|
|
|
CES1
|
[NCBI]
|
1.18493e-06
|
|
|
MUT
|
[NCBI]
|
1.18493e-06
|
|
|
GJA8
|
[NCBI]
|
1.18493e-06
|
|
|
PRKAR1A
|
[NCBI]
|
1.18493e-06
|
|
|
KL
|
[NCBI]
|
1.18493e-06
|
|
|
IFNGR1
|
[NCBI]
|
1.18493e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
1.18365e-06
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
1.18365e-06
|
|
|
SMA2
|
[NCBI]
|
1.18365e-06
|
|
|
ABCC8
|
[NCBI]
|
1.18087e-06
|
|
|
AIRE
|
[NCBI]
|
1.158e-06
|
|
|
CD
|
[NCBI]
|
1.10107e-06
|
|
|
FFI
|
[NCBI]
|
1.10107e-06
|
|
|
IPF1
|
[NCBI]
|
1.08287e-06
|
|
|
PITX2
|
[NCBI]
|
1.08287e-06
|
|
|
SMPD1
|
[NCBI]
|
1.08287e-06
|
|
|
APEX
|
[NCBI]
|
1.08287e-06
|
|
|
HMGA2
|
[NCBI]
|
1.08287e-06
|
|
|
IGF2R
|
[NCBI]
|
1.08287e-06
|
|
|
ARSB
|
[NCBI]
|
1.08287e-06
|
|
|
THRA
|
[NCBI]
|
1.08287e-06
|
|
|
TCOF
|
[NCBI]
|
1.0331e-06
|
|
|
CPE
|
[NCBI]
|
1.027e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
9.91305e-07
|
|
|
MHS1
|
[NCBI]
|
9.91305e-07
|
|
|
FCMD
|
[NCBI]
|
9.91305e-07
|
|
|
AN2
|
[NCBI]
|
9.91305e-07
|
|
|
CHGA
|
[NCBI]
|
9.8766e-07
|
|
|
ETV6
|
[NCBI]
|
9.8766e-07
|
|
|
RCDP1
|
[NCBI]
|
9.58532e-07
|
|
|
EVC
|
[NCBI]
|
9.58532e-07
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
9.58532e-07
|
|
|
GJB1
|
[NCBI]
|
9.52669e-07
|
|
|
FGF1
|
[NCBI]
|
9.42712e-07
|
|
|
CNTF
|
[NCBI]
|
9.32224e-07
|
|
|
FGA
|
[NCBI]
|
9.06296e-07
|
|
|
GRIN1
|
[NCBI]
|
8.98847e-07
|
|
|
CD40LG
|
[NCBI]
|
8.98847e-07
|
|
|
ATXN1
|
[NCBI]
|
8.98847e-07
|
|
|
CSTB
|
[NCBI]
|
8.98847e-07
|
|
|
NCOA3
|
[NCBI]
|
8.98847e-07
|
|
|
GCDH
|
[NCBI]
|
8.98847e-07
|
|
|
STAT4
|
[NCBI]
|
8.98847e-07
|
|
|
CAV3
|
[NCBI]
|
8.98847e-07
|
|
|
PPR
|
[NCBI]
|
8.93152e-07
|
|
|
SLOS
|
[NCBI]
|
8.66681e-07
|
|
|
GRA
|
[NCBI]
|
8.54387e-07
|
|
|
MLH1
|
[NCBI]
|
8.53876e-07
|
|
|
ERCC2
|
[NCBI]
|
8.16034e-07
|
|
|
IRF3
|
[NCBI]
|
8.16034e-07
|
|
|
ALDH3A2
|
[NCBI]
|
8.16034e-07
|
|
|
CRY1
|
[NCBI]
|
8.16034e-07
|
|
|
DCN
|
[NCBI]
|
8.16034e-07
|
|
|
SLC40A1
|
[NCBI]
|
8.16034e-07
|
|
|
TP53
|
[NCBI]
|
7.73147e-07
|
|
|
usher syndrome, type i
|
[NCBI]
|
7.61986e-07
|
|
|
HSAS
|
[NCBI]
|
7.61986e-07
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
7.61986e-07
|
|
|
TLR2
|
[NCBI]
|
7.59094e-07
|
|
|
BTK
|
[NCBI]
|
7.43431e-07
|
|
|
TERT
|
[NCBI]
|
7.41607e-07
|
|
|
KRT5
|
[NCBI]
|
7.38859e-07
|
|
|
IL12B
|
[NCBI]
|
7.38859e-07
|
|
|
MTND6
|
[NCBI]
|
7.38859e-07
|
|
|
FASN
|
[NCBI]
|
7.38859e-07
|
|
|
glioma of brain, familial
|
[NCBI]
|
7.25998e-07
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
7.25998e-07
|
|
|
LNS
|
[NCBI]
|
7.25998e-07
|
|
|
BRRS
|
[NCBI]
|
7.25998e-07
|
|
|
DNMT3B
|
[NCBI]
|
6.66989e-07
|
|
|
CLCN1
|
[NCBI]
|
6.66989e-07
|
|
|
CDKN1A
|
[NCBI]
|
6.66989e-07
|
|
|
EWSR1
|
[NCBI]
|
6.66989e-07
|
|
|
GRPR
|
[NCBI]
|
6.66989e-07
|
|
|
SVAS
|
[NCBI]
|
6.49028e-07
|
|
|
CMT1B
|
[NCBI]
|
6.06498e-07
|
|
|
CSA
|
[NCBI]
|
6.06498e-07
|
|
|
neuroblastoma
|
[NCBI]
|
6.06498e-07
|
|
|
GSN
|
[NCBI]
|
6.00121e-07
|
|
|
PEPD
|
[NCBI]
|
6.00121e-07
|
|
|
NBS1
|
[NCBI]
|
6.00121e-07
|
|
|
RARA
|
[NCBI]
|
6.00121e-07
|
|
|
CDK6
|
[NCBI]
|
6.00121e-07
|
|
|
SPG4
|
[NCBI]
|
6.00121e-07
|
|
|
ZFP36
|
[NCBI]
|
5.96728e-07
|
|
|
FMR1
|
[NCBI]
|
5.92234e-07
|
|
|
apert syndrome
|
[NCBI]
|
5.91965e-07
|
|
|
GDF5
|
[NCBI]
|
5.37977e-07
|
|
|
STAT5B
|
[NCBI]
|
5.37977e-07
|
|
|
GHRL
|
[NCBI]
|
5.37977e-07
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
5.37977e-07
|
|
|
MECP2
|
[NCBI]
|
4.97593e-07
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
4.96275e-07
|
|
|
LWD
|
[NCBI]
|
4.96275e-07
|
|
|
coproporphyria
|
[NCBI]
|
4.80301e-07
|
|
|
NTRK2
|
[NCBI]
|
4.80301e-07
|
|
|
CTCF
|
[NCBI]
|
4.80301e-07
|
|
|
BCL6
|
[NCBI]
|
4.80301e-07
|
|
|
BSG
|
[NCBI]
|
4.62478e-07
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
4.46641e-07
|
|
|
DKC
|
[NCBI]
|
4.46641e-07
|
|
|
LSA
|
[NCBI]
|
4.46641e-07
|
|
|
homocysteinemia
|
[NCBI]
|
4.46641e-07
|
|
|
MAFD2
|
[NCBI]
|
4.31936e-07
|
|
|
ARNT
|
[NCBI]
|
4.31001e-07
|
|
|
FOXO1A
|
[NCBI]
|
4.26859e-07
|
|
|
glycogen storage disease i
|
[NCBI]
|
4.26859e-07
|
|
|
ADRP
|
[NCBI]
|
4.26859e-07
|
|
|
JAK1
|
[NCBI]
|
4.26859e-07
|
|
|
APOC2
|
[NCBI]
|
4.26859e-07
|
|
|
SLC26A4
|
[NCBI]
|
4.26859e-07
|
|
|
SOD1
|
[NCBI]
|
4.0644e-07
|
|
|
SNCA
|
[NCBI]
|
4.00398e-07
|
|
|
aortic valve disease
|
[NCBI]
|
3.95741e-07
|
|
|
RS1
|
[NCBI]
|
3.77433e-07
|
|
|
PTPRC
|
[NCBI]
|
3.77433e-07
|
|
|
PDE6B
|
[NCBI]
|
3.77433e-07
|
|
|
SHOX
|
[NCBI]
|
3.77433e-07
|
|
|
JAG1
|
[NCBI]
|
3.77433e-07
|
|
|
GHR
|
[NCBI]
|
3.73184e-07
|
|
|
MTTL1
|
[NCBI]
|
3.70692e-07
|
|
|
FAAH
|
[NCBI]
|
3.66555e-07
|
|
|
BMP2
|
[NCBI]
|
3.41904e-07
|
|
|
AGTR1
|
[NCBI]
|
3.31823e-07
|
|
|
DSG1
|
[NCBI]
|
3.31823e-07
|
|
|
FPLD2
|
[NCBI]
|
3.24366e-07
|
|
|
LAD
|
[NCBI]
|
3.05335e-07
|
|
|
ABL
|
[NCBI]
|
3.05335e-07
|
|
|
NF1
|
[NCBI]
|
2.9564e-07
|
|
|
TBP
|
[NCBI]
|
2.95405e-07
|
|
|
SMN2
|
[NCBI]
|
2.89841e-07
|
|
|
EDN1
|
[NCBI]
|
2.89841e-07
|
|
|
fucosidosis
|
[NCBI]
|
2.89841e-07
|
|
|
LBP
|
[NCBI]
|
2.83005e-07
|
|
|
PAX6
|
[NCBI]
|
2.61289e-07
|
|
|
SMN1
|
[NCBI]
|
2.57501e-07
|
|
|
PDHA1
|
[NCBI]
|
2.51316e-07
|
|
|
H19
|
[NCBI]
|
2.51316e-07
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.51316e-07
|
|
|
HBB
|
[NCBI]
|
2.47791e-07
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
2.25529e-07
|
|
|
VMD
|
[NCBI]
|
2.25529e-07
|
|
|
XPA
|
[NCBI]
|
2.25529e-07
|
|
|
gastric cancer
|
[NCBI]
|
2.23652e-07
|
|
|
cystinuria
|
[NCBI]
|
2.23652e-07
|
|
|
THRB
|
[NCBI]
|
2.1259e-07
|
|
|
VCP
|
[NCBI]
|
2.1259e-07
|
|
|
MEN1
|
[NCBI]
|
2.10593e-07
|
|
|
PMP22
|
[NCBI]
|
2.03651e-07
|
|
|
TSC2
|
[NCBI]
|
1.89835e-07
|
|
|
PENK
|
[NCBI]
|
1.89835e-07
|
|
|
MTCYB
|
[NCBI]
|
1.84004e-07
|
|
|
HAE
|
[NCBI]
|
1.56827e-07
|
|
|
FGFR1
|
[NCBI]
|
1.55167e-07
|
|
|
ENG
|
[NCBI]
|
1.54926e-07
|
|
|
LGMD2A
|
[NCBI]
|
1.43153e-07
|
|
|
SPG3A
|
[NCBI]
|
1.43153e-07
|
|
|
glycogen storage disease vii
|
[NCBI]
|
1.43153e-07
|
|
|
PGL1
|
[NCBI]
|
1.43153e-07
|
|
|
DAZ
|
[NCBI]
|
1.28724e-07
|
|
|
IL2RA
|
[NCBI]
|
1.28724e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.10147e-07
|
|
|
ATRX
|
[NCBI]
|
1.05274e-07
|
|
|
VLDLR
|
[NCBI]
|
1.05274e-07
|
|
|
CDSP
|
[NCBI]
|
9.97705e-08
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
9.97705e-08
|
|
|
CCL17
|
[NCBI]
|
9.32206e-08
|
|
|
ABCA1
|
[NCBI]
|
8.44627e-08
|
|
|
DMPK
|
[NCBI]
|
8.44627e-08
|
|
|
DCT
|
[NCBI]
|
8.44627e-08
|
|
|
TNFRSF6
|
[NCBI]
|
8.44627e-08
|
|
|
L1CAM
|
[NCBI]
|
8.44627e-08
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
8.44627e-08
|
|
|
CTSC
|
[NCBI]
|
8.44627e-08
|
|
|
TSC1
|
[NCBI]
|
8.44627e-08
|
|
|
EVA
|
[NCBI]
|
8.16429e-08
|
|
|
CMD1A
|
[NCBI]
|
8.16429e-08
|
|
|
myoclonic dystonia
|
[NCBI]
|
8.16429e-08
|
|
|
SPG4
|
[NCBI]
|
8.16429e-08
|
|
|
HCH
|
[NCBI]
|
8.16429e-08
|
|
|
APRT
|
[NCBI]
|
7.88202e-08
|
|
|
HBG2
|
[NCBI]
|
6.61818e-08
|
|
|
BCL2
|
[NCBI]
|
6.32116e-08
|
|
|
POAG
|
[NCBI]
|
5.49419e-08
|
|
|
SMEI
|
[NCBI]
|
5.49419e-08
|
|
|
FOP
|
[NCBI]
|
5.49419e-08
|
|
|
CPI
|
[NCBI]
|
5.12712e-08
|
|
|
AKT1
|
[NCBI]
|
5.03302e-08
|
|
|
COL3A1
|
[NCBI]
|
5.03302e-08
|
|
|
WAS
|
[NCBI]
|
5.03302e-08
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
4.596e-08
|
|
|
CVID
|
[NCBI]
|
4.58153e-08
|
|
|
CDK4
|
[NCBI]
|
4.42009e-08
|
|
|
MCP
|
[NCBI]
|
4.15788e-08
|
|
|
SPTA1
|
[NCBI]
|
3.85883e-08
|
|
|
MMP2
|
[NCBI]
|
3.85883e-08
|
|
|
CADASIL
|
[NCBI]
|
3.80045e-08
|
|
|
PCTT
|
[NCBI]
|
3.80045e-08
|
|
|
CACNA1A
|
[NCBI]
|
3.68125e-08
|
|
|
factor vii deficiency
|
[NCBI]
|
3.68125e-08
|
|
|
NF2
|
[NCBI]
|
2.84011e-08
|
|
|
DAO
|
[NCBI]
|
2.55391e-08
|
|
|
DSG3
|
[NCBI]
|
2.55391e-08
|
|
|
HS
|
[NCBI]
|
2.55391e-08
|
|
|
HHF1
|
[NCBI]
|
2.29677e-08
|
|
|
AQP4
|
[NCBI]
|
1.96901e-08
|
|
|
PKD2
|
[NCBI]
|
1.96901e-08
|
|
|
HRAS
|
[NCBI]
|
1.96901e-08
|
|
|
HPRT1
|
[NCBI]
|
1.8997e-08
|
|
|
FGFR2
|
[NCBI]
|
1.74656e-08
|
|
|
CDH1
|
[NCBI]
|
1.25028e-08
|
|
|
FIH
|
[NCBI]
|
1.12167e-08
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
1.12167e-08
|
|
|
OPA1
|
[NCBI]
|
1.12167e-08
|
|
|
MDLS
|
[NCBI]
|
1.12167e-08
|
|
|
TLR9
|
[NCBI]
|
9.3802e-09
|
|
|
APP
|
[NCBI]
|
8.71001e-09
|
|
|
AT
|
[NCBI]
|
4.843e-09
|
|
|
HYPP
|
[NCBI]
|
4.52449e-09
|
|
|
PDS
|
[NCBI]
|
4.52449e-09
|
|
|
ITGB2
|
[NCBI]
|
4.36051e-09
|
|
|
COL1A1
|
[NCBI]
|
3.07107e-09
|
|
|
RPGR
|
[NCBI]
|
2.90191e-09
|
|
|
CEL
|
[NCBI]
|
2.90191e-09
|
|
|
NFKB1
|
[NCBI]
|
2.90203e-11
|
|